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ABSTRACT 
Milk proteins represent an important source of protein ingredients due to their 
distinctive physico-chemical, nutritional, technological and functional properties. Case in 
content of milk represents about 80% of milk proteins. The distinguishing property of 
phosphorylation provides important properties to caseins. The objectives of this research 
were to investigate enzymatic dephosphorylation of caseins, to characterize products of 
dephosphorylation and to examine the effects of dephosphorylation on biological 
properties of caseins. 
Bovine whole casein, {X-casein and ~-casein were dephosphorylated with potato 
acid phosphatase; optimum dephosphorylation conditions were 37 oC, pH 5.8 for 6 h. The 
extents of dephosphorylation accounted for 71.6, 89.2 and 73.7% for whole casein, {X-
casein and ~-casein, respectively. The apparent Vmax and apparent Km for 
dephosphorylation of whole casein were 0.283 !-lmol P/mg casein min and 9.951 mg 
casein/l, respectively. SDS-PAGE, urea-PAGE, RP-HPLC and ESI-MS demonstrated 
effects of dephosphorylation on the caseins. Urea-PAGE and ESI-MS confirmed the 
identities of the individual fractions. ESI-MS established (a) the molecular weight for {X-
casein and ~-casein as 23, 612 and 24, 017 Da, respectively; (b) random removal of 1,2, 
4,6, 7 and 8 phosphate groups from (X-casein and 1,2, 3,4 and 5 phosphate groups from 
~-casein and (c) effects of incubation conditions. The effects of dephosphorylation of {X-
casein and ~-casein on the action of pep sin and trypsin were evaluated. Peptide maiJping 
by RP-HPLC indicated that both proteases generated a complex mixture of peptides, with 
dephosphorylated peptides showing an increase in retenti on time. LC-ESI-MS and 
MS/MS in conjunction with the use of advanced bioinformatics software resulted in the 
identific~tion of the peptides generated. Dephosphorylated a-casein and ~-casein showed 
the presence of peptides in which phosphate groups were removed, and were not observed 
in peptides from the corresponding native protein. Several of the peptides identified 
contained sequences that have been reported to be biologically active. Residual 
allergenicity of dephosphorylated whole casein, a-casein and ~-casein as weIl as peptic 
and tryptic products of these caseins was determined by an ELISA technique. The results 
demonstrated that removal of phosphate groups from whole case in, a-casein and ~-casein 
reduced allergenicity by 33, 31.2 and 24.4%, respectively. Proteolysis and 
dephosphorylation resulted in a significantly (p < 0.05) higher reduction in the antigen-
antibody binding capacity compared to non-hydrolyzed and non-dephosphorylated 
caseins, particularly in the highly allergenic a-casein. 
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RÉSUMÉ 
Les protéines du lait constituent une source importante d'ingrédients protéiniques 
grâce à leurs propriétés caractéristiques physico-chimiques, nutritionnelles, 
technologiques et fonctionnelles. La teneur en caséine du lait représente environ 80% des 
protéines du lait. La propriété distinctive de la phosphorylation dote les caséines 
d'importantes propriétés. Les objectifs de cette recherche étaient d'étudier la 
déphosphorylation enzymatique des caséines afin de caractériser les produits de 
déphosphorylation et d'examiner les effets de la déphosphorylation sur les propriétés 
biologiques des caséines. 
La caséine bovine entière, la a-caséine et la p-caséine ont été déphosphorylées 
avec la phosphatase acide de pomme de terre; les conditions optimales de 
déphosphorylation étaient 37 oC à pH 5.8 pendant 6 h. L'ampleur de la 
déphosphorylation atteignit 71.6, 89.2 et 73.7% pour la caséine entière, la a-caséine et la 
p-caséine, respectivement. La Vmax et Km apparente pour la déphosphorylation de la 
caséine entière étaient de 0.283 ~mol P/mg caséine min et 9.951 mg caséine/l, 
respectivement. Les méthodes SDS-PAGE, urea-PAGE, RP-HPLC et ESI-MS ont 
démontré des effets de déphosphorylation sur les caséines. Les méthodes urea-PAGE et 
ESI-MS ont confirmé les identités des fractions individuelles. La méthode ESI-MS a 
établi (a) le poids moléculaire pour la a-caséine et la p-caséine à 23, 612 et 24, 017 Da, 
respectivement; (b) l'élimination aléatoire des groupes de phosphate de a-caséine 1,2,4, 
6, 7 et 8 et des groupes de phosphate de p-caséine 1, 2, 3, 4 et 5 et (c) les effets des 
conditions d'incubation. L'influence de la déphosphorylation de a-caséine et de p-caséine 
sur l'action de la pepsine et la trypsine a été évaluée. Le traçage peptidique par la 
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méthode RP-HPLC a indiqué que les deux protéases ont produit un mélange de peptides 
complexe, les peptides déphosphorylés affichant une augmentation du temps de rétention. 
Les méthodes LC-ESI-MS et MSIMS couplées à l'utilisation d'un logiciel avancé en 
bioinformatique on permit l'identification des peptides obtenus. La a-caséine et la ~­
caséine déphosphorylées ont révélé la présence de peptides là où des groupes phosphates 
avaient été enlevés, et n'ont pas été observés dans les peptides de la protéine originale 
correspondante. Plusieurs des peptides identifiés, contenait des séquences ayant été 
rapportée comme étant biologiquement active. Le facteur allergénique résiduel de la 
caséine entière, la a-caséine et la ~-caséine déphosphorylées de même que les produits de 
la pepsine et trypsine de ces caséines a été déterminé à l'aide d'une technique ELISA. Les 
résultats ont démontré que l'élimination des groupes phosphate de la caséine entière, la a-
caséine et la ~-caséine a réduit le facteur allergénique de 33, 31.2 et 24.4%, 
respectivement. La dégradation enzymatique et la déphosphorylation ont donné une plus 
grande réduction significative (p < 0.05) de la capacité de liaison antigène-anticorps 
comparativement aux caséines non-hydrolysées et non-déphosphorylées, 
particulièrement pour la hautement allergéniqe a-caséine. 
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CLAIMS TO ORIGINAL RESEARCH 
1. This is the first study to investigate the effects of enzymatic dephosphorylation of 
whole casein and to report the apparent kinetic parameters for enzymatic 
dephosphorylation of whole casein using an acid phosphatase enzyme. 
2. This is the first study to investigate the extents of enzymatic dephosphorylation of a-
casein and ~-casein by determining casein molecular changes and dephosphorylated 
casein species which occur during dephosphorylation using electrospray ionization mass 
spectrometry (ESI-MS). 
3. This is the first study to evaluate the effects of dephosphorylation of a-casein and ~­
casein on peptic, tryptic and combined peptic-tryptic hydrolysis and to characterize an the 
proteolysis products by using ESI coupled with food proteomics tools, including analysis 
by specialized protein database software and search engines. 
4. This is the first study to investigate the effects of dephosphorylation and proteolysis on 
reduction in antigen-antibody binding of a mixture of dephosphorylated and peptic, 
tryptic and combined peptic-tryptic hydrolysis products of a-casein and ~-casein. 
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LIST OF AMINOACIDS, THEIR ABBREVIATION AND 
LINEAR STRUCTURE 
Amino Acid Three Single Linear Structure 
Letter Code Letter Code 
Alanine ala A CH3-CH(NH2)-COOH 
Arginine arg R HN=C(NH2)-NH-(CH2)3-CH(NH2)-COOH 
Asparagine asn N H2N -CO-CH2-CH(NH2)-COOH 
Aspartic Acid asp D HOOC-CH2-CH(NH2)-COOH 
Cysteine cys C HS-CH2-CH(NH2)-CO OH 
Glutamic Acid glu E HOOC-(CH2)2-CH(NH2)-COOH 
Glutamine gIn Q H2N -CO-(CH2)2-CH(NH2)-COOH 
Glycine gly G NH2-CH2-COOH 
Histidine his H NH-CH=N-CH=C-CH2-CH(NH2)-COOH 
Isoleucine ile l CH3-CH2-CH(CH3)-CH(NH2)-COOH 
Leucine leu L (CH3)2-CH-CH2-CH(NH2)-COOH 
Lysine lys K H2N-(CH2)4-CH(NH2)-CO OH 
Methionine met M CH3-S-(CH2)2-CH(NH2)-COOH 
Phenylalanine phe F Ph-CH2-CH(NH2)-COOH 
Proline pro P NH-(CH2)3-CH-COOH 
Serine ser S HO-CH2-CH(NH2)-COOH 
Threonine thr T CH3-CH(OH)-CH(NH2)-COOH 
Tryptophan - trp W Ph-NH-CH=C-CH2-CH(NH2)-COOH 
Tyrosine tyr Y HO-Ph-CH2-CH(NH2)-CO OH 
Valine val V (CH3 )2-CH -CH(NH2)-COOH 
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CHAPTERI 
INTRODUCTION 
1.1 General Introduction 
Milk consists of approximate1y 13% solids and 87% water; however, the solids 
content determines the value of milk (Jenness, 1988). Technology allows processors to 
disassemble milk into its various component parts; these can be combined in different 
ways to make new products or to be used as specific ingredients in other foods (Fox, 
2001). Milk composition is also of extreme importance to the consumer from a nutritional 
point of view; it contains a mixture of high value proteins, necessary amino acids and 
significant quantities ofinorganic salts (Murphy & Allen, 2003). 
In general, milk proteins are trusted by consumers as wholesome, natural and 
nutritious food components. In the food industry, milk proteins comprising of caseins and 
whey have been recognized by possessing essential functional and physicochemical 
properties as foods ingredients. The protein system in milk, especially in bovine milk, has 
been studied for nearly 200 years and very significant progress has been made during the 
past years (Fox & McSweeney, 1998). Although, the principal milk-specific proteins 
have been very well characterized already, the rapidly expanding tools of biotechnology 
are enabling a new perception of food proteins. Proteomics and their analyses are 
revealing the molecular details of the remarkable structural complexity and design of 
milk proteins (Chalkley et al., 2005). 
Milk caseins precipitate by acidification of milk; the whey proteins remam 
soluble (Wong et al., 1996). Casein has been produced commercially for at least 80 years. 
Initially casein was used for industrial purposes because of its good binding properties 
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(e.g., adhesives, paper coating, paints and cosmetics). However, ln the 1960's 
commercial case in preparations gained importance as food proteins, due mainly to 
pioneering work carried out in Australia and New Zealand. Presently, casein produced by 
acid or rennet coagulation, is one of the principal functional food proteins with an annual 
world production of approximately 250, 000 tonnes; case in is considered to posses 
unique properties and cannot be replaced by other proteins in certain food applications 
(Fox, 2001). us-casein and ~-casein are the major protein components ofmilk. 
A characteristic of caseins is their microheterogeneity with varyillg extents of 
phosphorylation and glycosylation. Caseins contain phosphate groups bound to serine 
and threonine. The phosphate groups of caseins are known to affect many characteristics 
of the protein including casein digestion and bioavailability of divaient cations. 
Additionally, caseins may influence the immune system causing allergenic reactions, 
especially as the phosphoseryl residues are considered to be immunoreactive and resistant 
to digestion. In most food applications there is growing interest in studying protein 
modifications that can pro vide new benefits and safety to the consumers. 
Modification of caseins without compromising their functional properties is 
desirable for many food applications. One approach to minimizing the undesirable 
biological effects of phosphorylated caseins is to remove the phosphate groups; this 
dephosphorylation can be achieved both chemically and enzymatically. 
1.2 Rationale and Objectives of Study 
Knowledge on milk proteins generally advances as new and more sophisticated 
analytical techniques are developed; milk proteins continue to be characterized in every 
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increasing detail. Even though, there is relative abundance of information in the literature 
on dephosphorylation of casein fractions, understanding of the effects on the properties of 
casein after post-translational modification of the phosphate groups and the 
characterization of dephosphorylation products are required. 
The overall objectives of this research were to investigate enzymatic dephosphorylation 
of caseins and to examine the effects of dephosphorylation on properties of caseins. The 
specific objectives ofthis study were: 
1. To enzymatically dephosphorylate whole casein, a-casein and p-casein, to 
investigate the kinetics and extent of dephosphorylation and to establish optimum 
dephosphorylation conditions of caseins. 
2. To investigate molecular characteristics of products of dephosphorylated whole 
casein, a-casein and p-casein using a combination of polyacrylamide gel electrophoresis 
(SDS and urea-PAGE), reversed phase high-performance liquid chromatography (RP-
HPLC) and electrospray ionization mass spectrometry (ESI-MS). 
3. To evaluate the effects of dephosphorylation on biological properties of 
caseins, including in vitro enzymatic hydrolysis simulating human gastric conditions and 
peptide mass mapping based on proteomic techniques, including liquid chromatography 
electrospray ionization mass spectrometry (LC-ESI-MS) and tandem mass spectrometry 
(MS/MS), followed by database search. 
4. To study the effects of dephosphorylation and in vitro enzymatic hydrolysis of 
caseins on allergy reduction evaluated by enzyme-linked immunosorbent assay (ELISA). 
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CHAPTER2 
LITERA TURE REVIEW 
2.1 Milk Proteins 
Bovine milk represents an important and valuable source of protein ingredients 
due to their recognized superior nutritional, organoleptic and functional properties of 
milk proteins (Singh, 2003). Milk is a polyphasic secretion of the mammalian gland and 
also a source of fat and lactose as food ingredients, contains 3.9% fat, 3.3% protein, 5% 
lactose and 0.7% mineraIs (Jenness, 1988). The milk proteins include several caseins, 
several whey proteins, fat globule membrane proteins and enzymes. The caseins are 
phosphoproteins and compromise approximately 80% of the total protein content in milk. 
Whey proteins represent 20% of the total milk proteins and consist mainly of u-
lactalbumin, B-Iactoglobulin, bovine serum albumin and immunoglobins (Farrell et al., 
2004). Both the caseins and whey protein fractions are quite heterogeneous and proteins 
within each group have very different molecular and physico-chemical properties. Some 
of the more important properties of the milk proteins are summarized in Table 2.1. A 
review of the information on properties of the caseins follows. 
2.2 Physicochemical Characteristics of Caseins 
Unlike many typical globular proteins, caseins are not present III milk as 
individual molecular structures, but rather as large protein complexes which also 
incorporate milk salts, particularly calcium phosphate. The native structure is a protein 
complex resulting from the interaction of all the individual caseins. Neverthek:ss, 
4 
Vl 
Table 2.1: Characteristics of the principal proteins in bovine milk (Ng-Kwai-Hang, 2003) 
Molecular 
Protein Mass 
(Da) 
Amino acid 
Residues 
P04 
residues 
Genetic variants detected 
il T~tal !f Pro IFI ! 
r------.----~' cc,c,cc_,c~_~cc~ ccccc""cc",,,c,,,c" - ccc c, ,c,c,~~' c 'cc ~c~c~ccceccc ccc ,cec" eCce 
1 ~~l-casein ,le 23 614 lq~~~~ q il ",1~qJr-CS-IA,~~:~'.~'.E, ~'.~:m~ 
1 as~-~asein 1 25 38~m!tm 20~cJ[lO,LI ,10~1~cjl~*-,B,C,Dc ,C,C"CC"q 
1 ~-casein 123 983 ~120~ il 351r-~1 A\A2*,~3,~,C,~,E,F,G 
I~~c~~ein ,,/., 19 038JL_cl~9,~JL2~." 1[.~ ,,'~~~:~~~' ~:~_S:~mI:,~S:m~~'~' l, J 
~-lactoglobulin 1 18277 . :/q162ilq8q ,r-I 0 l~'~*'c~' D, E,~,~,I,J 
a-lactalbumin 1 14175, ,il .. 12~qlr-r-GIA,B*,C 
Iserumalbumin 1 66267},5,82 T~rsl 0 ,rI ~~~~~~-~ 
* Molecular mass for the genetic variant 
knowledge of the physicochemical behavior of the individual caseins provides for an 
understanding of their individual structures as weIl as how these structures may interact 
to form the casein micelle. 
2.2.1 Casein Structure 
Casein micelles are the colloidal aggregates of caseins and mineraI calcium 
phosphate. Destabilization of the case in micelles results in coagulation or gelation, which 
is exploited in the production of a range of dairy products (Home, 2003). In the most 
widely accepted casein micelle model, the casein micelle is composed of sub-micelles 
(Schmidt, 1982). The sub-micelles are held together by nano-crystals of calcium 
phosphate and by hydrophobic and hydrogen bonds. This rearrangement results in the 
whole micelle having a hairy appearance (Figures 2.1 and 2.2). 
Caseins have low levels of secondary and tertiary structure (Farrell, 1988). They 
are neither globular proteins nor truly random coil polymers. They are rheomorphic 
proteins, adopting open and flexible structures in solution dictated by the environmental 
circumstances in which they find themselves (Swaisgood, 1982). Caseins have little (X-
helical structure, no denaturation temperature and hydrodynamic volumes (Sawyer & 
Holt, 1993). Their open conformation allows relatively easy access to proteolytic 
enzymes, facilitating rapid and extensive proteolysis. Caseins are stable to denaturing 
agents, e.g. urea, and they possess high surface activity (Home, 2003). 
The three-dimensional structure of the major caseins cannot be determined by X-
ray crystallography (caseins cannot be crystallized) or by nuclear magnetic resonance 
(NMR) spectroscopy (Swaisgood, 2003), this is because it is not possible to dissolve the 
caseins at a sufficient high concentration at which the native-like monomeric structure is 
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Figure 2.1: Schematic representations of a submicelle and a casein micelle composed 
of submicelles (Schmidt, 1982) 
Figure 2.2: Schematic dia gram of the binding of two submicelles via Ca9(P04)6 
clusters (Schmidt, 1982) 
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retained. Estimates of structural features have been made by using prediction methods, 
from peptide structures determined by NMR spectroscopy and from physicochemical 
studies (Kumosinski et al., 1994). 
2.2.2 Heterogeneity of Caseins 
Whole casein is isolated from milk by destabilizing the micelle suspension and 
can be fractionated to give several individual caseins. Bovine case in consists of the 
following four caseins: cx.s!-, cx.s2-, p- and K-casein. These represent approximately 37, 10, 
35 and 12% respectively, of whole casein (Fox & McSweeney, 1998). The molecular 
weight of caseins varies from 20 to 25 kDa. AlI caseins contain high levels of proline 
which prevents the formation of cx.-helices, p-sheets and p-turns (Ng-Kwai-Hang, 2003). 
Caseins are very heterogeneous with few structural features in common. This 
heterogeneity is complicated by their genetic polymorphism, resulting in several variants 
for each protein (Farrell et al., 2004). To date, 32 variants of the bovine caseins have been 
identified; genetic polymorphism is normally detected either by electrophoresis, when 
substitutions cause a change in charge or when substitutions involving uncharged 
residues (silent substitution) can be detected by mass spectrometry (Fox & Kelly, 2003). 
Caseins contain phosphate bound to the amino acid serine and occasionally threonine. 
The caseins are relatively hydrophobic and have a high surface hydrophobicity due to 
their open structure. The hydrophobie, polar and charged residues are not uniforrnly 
distributed through the sequences but occur as hydrophobic or hydrophilic patches, 
giving the caseins strongly amphiphatic structures, which make them highly surface 
active (O'Connell et al., 2003). 
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usl-casein contains eight phosphate residues located in the hydrophilic region 
between residues 45 and 89 (Swaisgood, 2003). usl-casein has the highest negative 
charge (22 at pH 6.5); it contains more acidic amino acids than basic ones (Wong et al., 
1996). Both prediction and spectral methods indicate 24% helical structure in usl-casein 
(HoIt & Sawyer, 1988); this little discernible secondary structure may be due to the 8.5% 
proline content distributed in the polypeptide chain. Three hydrophobic regions are 
identified in the residues: 1 to 44, 90 to 113 and 132 to 199. Variant A differs by a 
deletion of 13 residues (14 to 26) in the N-terminal sequence; the sequence 41-80 is very 
polar due to the presence of seven seryl phosphate residues, eight glutamates and three 
aspartates (Ng-Kwai-Hang, 2003). The C and D variants consist of Gly, Thr-P and Glu, 
and Ala at positions 192 and 53, respectively; the five genetic variants A, B, C, D and E 
show a decreasing electrophoretic mobility in urea alkaline gels; these variants constitute 
the major components of usl-casein (Wong et al., 1996). Variants F, Gand H have been 
recently reported (Farrell et al., 2004). uso-casein is a minor component identified (Eigel 
et al., 1984); it has the same amino acid sequence as usl-casein B-8P but contains one 
additional phosphoseryl residue at position 41. 
us2-casein is phosphorylated at various extents, containing 10, Il, 12 or 13 
phosphate residues; the reference casein for this family is u s2-casein A-IIP (Farrell et al., 
2004). uS2-casein shows similar characteristics to usl-casein except that there is a 
minimum association at a NaCI concentration of about 0.2 mollI (Creamer, 2003). U s2-
contains 2 cysteine residues at position 36 and 40 and it can occur as disulphide-linked 
dimers of us2-casein A-12P and u s2-casein A-IIP (Rasmussen et al., 1994). Four variants 
are known, A, B, C and D. The complete amino acid sequence of u s2-casein A-IIP 
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consists of 207 residues (Swaisgood, 1992). The polypeptide chain consists of a large 
number of positively charged side chains, especially in the C-terminal segment in the 
regions: 5 to 18, 49 to 68 and 126 to 145; it possesses a large hydrophilic region 90 to 
120 (Creamer, 2003). us2-casein contains a low proline content and among caseins is the 
least hydrophobie (Farrell et al., 2004). The segments 50 to 123 and 130 to 207 contain 
38% identical residues, indicating high internaI homology a possible resuIt of a duplicate 
primitive gene (Wong et al., 1996). 
p-casein contains five phosphate residues; sorne p-casein molecules contain four 
phosphate residues (Fox & Kelly, 2003). The reference casein for this family is p-casein 
Al-5P which is a single polypeptide chain of 209 residues (Ribadeau Dumas et al., 
1972). Seven genetic variants have been identified, Al, A2, A3, B, C, D and E (Eigel et 
al., 1984); recently variants F, Gand H have been reported (Farrell et al., 2004). The 
absence of cysteine from U s!- and p-casein increases their flexibility (Wong et al., 1996). 
p-casein has a high negative charge located in the N-terminal segment (1 to 43) 
containing all the phosphoseryl residues. Half of the C-terminal (residues 136-209) is 
highly hydrophobie (Cassiano & Areas, 2003); this concentration of hydrophilic and 
hydrophobie residues in the terminal ends makes p-casein the most surfactant casein 
among the others. Plasmin (a protease in milk) can cause a proteolytic effect of p-casein 
generating y-caseins by cleaving 28-29 and 105-106/107-108 bonds (Swaisgood, 2003). 
p-casein contains very low contents of periodic structure, approximately 13% of 
predicted helical content (HoIt & Sawyer, 1988). 
K-casein contains one or two phosphate groups. The only glycosylated case in is K-
casein. It contains galactose, galactosamine and N-acetylneuraminic acid which occur 
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either as trisaccharides or tetrasaccharides attached to threonine residues in the C-
terminal region (Fox & Kelly, 2003); the presence of oligosaccharides increases K-casein 
hydrophilicity. The N-termina12/3 ofk-casein is hydrophobic while the C-terminall/3 i., 
strongly hydrophilic; this structural feature is significant for the properties and stability of 
casein micelles (Sood et al., 2003). The primary structure ofK-casein contains 169 amino 
acid residues. The amphiphatic character of K-casein enhances the formation of micelles 
in solution (Swaisgood, 2003); unlike the other casein, K-casein does not bind calcium 
extensively and it is not sensitive to calcium precipitation. The genetic variants of K-
casein are A, B, C, E FS, FI, GS, GE, H, 1 and J (Ng-Kwai-Hang, 2003). K-casein occurs in 
the form of a mixture of disulfide-bonded polymers (Groves et al., 1992). K-casein 
structure can be affected by chymosin (rennin), the bond 105-106 is the c1eavage site that 
generates para-K-casein (residues 1-105) and the macropeptide (residues 106-169) 
(Bingham, 1975). The stability of the casein micelle depends on the presence of k-casein 
on the surface of the micelle where it functions as an interface between the hydrophobic 
caseins (Creamer et al., 1998). 
2.2.3 Phosphorylated Caseins 
Milk contains about 900 mg phosphorus/l, which occurs in five types of 
phosphate-containing compounds inc1uding: inorganic phosphorus, insoluble and 
colloidal phosphates; organic phosphorus in phospholipids, case in and sugars phosphates 
and nuc1eotides. Whole case in contains about 0.85% phosphorous, (ls!-, p- and K-caseins 
contain 1.1, 0.6 and 0.16% P, respectively (Fox & McSweeney, 1998). The phosphate 
groups are esterified as monoesters of serine or, to a minor extent of threonine. 
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Adenosine triphosphate (ATP) provides the phosphate and phosphorylation is catalyzed 
by casein kinase. A specifie sequence, Ser.X.A (where X is any amino acid and A is an 
anionic residue, i.e. Glu, Asp or SerP) is required for phosphorylation. Most of the 
phosphoserine residues in casein are present in clusters (Fox & Kelly, 2003). A 
phosphate cluster occurs when the phosphoseryl residues are concentrated within a short 
length of the polypeptide chain as shown in Figure 2.3. The phosphorus is covalently 
bound to the protein and is removed only by severe heat treatment, high pH or some 
phosphatases. Phosphate groups are important in many aspects: nutritionally, because 
they bind large amounts of Ca2+ (Lopez-Huertas et al., 2006). However, they also bind 
Zn2+ and other polyvalent cations strongly (Bouhallab & BougIe, 2004). They increase 
the solubility of caseins; and they probably contribute to the high heat stability of casein 
(Besler et al., 2001). 
2.3 Modification of Caseins 
Modification of proteins is used in protein chemistry to study the relationship 
between structure and biological functions. It is also used extensively to improve the 
functional properties of food proteins with potential applications in the food industry. 
2.3.1 Chemical Modification 
The chemical process of modifying caseins usually involves acetylation, 
phosphorylation, dephosphorylation, succylation, deamidation, decarboxylation, 
esterification, glycosylation, reductive alkylation, sulfitolysis and thiolation of isolated 
and purified proteins (Means & Feeney, 1990). Processes for modification of caseins to 
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Figure 2.3: Primary structure of <X.sl-casein, indicating the presence of phosphate clusters (Mercier et al., 1971) 
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meet the requirements of food products and pharmaceutical industries have been 
developed (Arai et al., 1986). Certain functional groups of amino acid residues (amino, 
carboxyl, disulfide, guanidine, hydroxyl, indole, imidazole, phenolic, sulfhydryl and 
thioether) are the target for physicochemical manipulation that lead to the formation of 
products with enhanced functionalities compared to the native proteins (Feeney, 1987). 
Caseins serve as functional food additives, contributing adhesive, emulsion, coagulation, 
or viscoelastic properties to foods by means of hydrophobie associations and electrostatic 
interactions (Kinsella, 1984). However caseins have a minimal number of sulfhydryl 
groups. Disulfide-sulfhydryl interactions are important forces in the conformation ami 
activity of the protein. Sulfhydryl groups were introduced to us!-casein by the process of 
thiolation resulting in a very stable foam of this casein (Okumura et al., 1990); foam 
stability is affected by the tertiary structure of proteins, which was stabilized by disulfide 
bonds. p-casein was esterified to different extents by using different alcohols; after this 
modification the emulsifying activity and stability of esterified p-casein in the acidic pH 
range of 3-5 were generally higher compared to the corresponding native proteins (Sitohy 
et al., 2001). The effects of chemical glycosylation and increase of the ionic strength of 
U s!- and p-casein were evaluated (Cayot et al., 1991); it was demonstrated that after 
chemical modification there was an improvement in the solubility of these caseins and 
glycosylation had an improvement on the emulsifying properties of a mixture of U s!-
casein, p-casein and galactosylated p-casein. 
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2.3.2 Enzymatic Modification 
The use of enzymes to modify the structure of caseins provides a more systematic 
approach since enzymes are specific and enzymatic reactions can be controlled more than 
chemical reaction. The principles and methods for casein enzymatic modification include 
the use of rennet, bacteria proteinases and peptidase during cheese production (Fox, 
1988). The classic example of enzyme modification of milk proteins is the action of 
chymosin, which cleaves the sensitive bond Phe\Os-Met\06 of K-casein (Fox et al., 1990); 
this triggers a sequence of events that lead to the aggregation of case in micelles that 
encapsulate sorne fats to form cheese curd. Proteolysis in cheese is affected by many 
factors including activity ofresidual rennet and indigenous milk proteases (Grappin et al., 
1985); this type of protein modification affects both the texture and flavor of the chee se 
in which occurs. 
Bioactive peptides formation is another approach to modify caseins, when caseins 
are digested by proteolytic enzymes such as pepsin, trypsin and chymotrypsin (Torres-
Llanez Mde et al., 2005). Other approaches to modify caseins include transglutamination, 
deamination, dephosphorylation and, succinylation (Imafidon et al., 1997). For example, 
<Xsl-casein and ~-casein can be modified with more amphiphilic structure and higher 
surfactancy than the native casein by succinylating (Schwenke et al., 1981). 
2.3.3 Dephosphorylation 
2.3.3.1 Chemical Dephosphorylation 
Dephosphorylation of casein occurs as a result of alkaline hydrolysis, releasing 
phosphate and producing serine. Dephosphorylation can also proceed through a p-
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elimination reaction producing dehydroalanine residues capable of intermolecular or 
intramolecular reaction with lysine to form lysinoalanine. The optimum pH for the 
reaction is 12 (Ward & Bastian, 1998). The use of hydrotluoric acid has been also 
applicable to remove phosphate moieties from phosphoproteins and peptides, including 
a-casein, without any cleavage of other bonds. The phosphate ester linkage of serine, 
threonine or tyrosine was successfully cleaved despite the high acidity of hydrotluoric 
acid (Kuyama et al., 2003). Sorne of the chemical reactions available for intentional 
prote in modification can be replaced by enzymatic reactions, which have the advantage 
of milder reaction conditions. 
2.3.3.2 Enzymatic Dephosphorylation 
Enzymatic dephosphorylation of milk proteins ismore acceptable to the food 
processors than those from chemical alterations (Rolle, 1998). Dephosphorylation of 
caseins by enzymes results in release of the phosphate group and the serine residue is 
preserved. Milk contains both alkaline and acid phosphatases, which are 
phosphomonoesterases capable of dephosphorylating phosphoserine residues. A variety 
of phosphatases have been used to remove the phosphate groups from casein (Li-Chan & 
Nakai, 1989; Lorient & Linden, 1976). However, acid phosphatase from potato shows 
several advantages; it does not require activators, is active at pH 7, can be obtained 
commercially in a highly purified form and hydrolyzes only monoesters of phosphate. 
Acid phosphatase has a molecular weight of approximately 42, 000 and has a pH 
optimum of 4.9 using p-nitrophenyl phosphate as substrate (Bingham et al., 1976). 
Alkaline phosphatase is a dimer with a molecular weight of approximately 160 000-190 
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000 Da and contains four to five Zn atoms per molecule (Andrews, 1992).The pH 
optimum for dephosphorylation of isolated CN in buffered solutions is between 6 and 7 
(Lorient & Linden, 1976). Studies on dephosphorylation of individual caseins by 
alkaline phosphatase have been conducted. Lorient & Linden (1976) reported a more 
efficient dephosphorylation of individual a-casein, p-casein and K-casein rather than 
mixtures of the same caseins; however at alkaline pH required for this phosphatase the 
presence of lactose, whey proteins and phosphate ions has an inhibitory effect on alkaline 
phosphatase. (Li-Chan & Nakai (1989) investigated the dephosphorylation of caseins 
with calf intestinal alkaline phosphatase and potato acid phosphatase. Incubation with the 
first enzyme produced a lower percentage in dephosphorylation when compared with the 
acid phosphatase results. Dephosphorylation of whole casein was less efficient than 
dephosphorylation of individual casein fractions. Dephosphorylation of bovine skim milk 
with acid phosphatase indicated a resistance of the case in micelles to the enzyme. p-
casein and a derived phosphopeptide were dephosphorylated by Escherichia coli alkaline 
phosphatase and bovine spleen phosphoprotein phosphatase (West & Towers, 1976); the 
first enzyme was able to remove phosphate groups in two stages, since casein molecules 
retaining three of the original phosphoseryl residues were resistant to further 
dephosphorylation at low enzyme concentrations. In contrast, complete 
dephosphorylation of these caseins was achieved by bovine spleen phosphoprotein 
phosphatase without any inhibition. Pearse et al. (1986) studied the dephosphorylation of 
p-casein and K-casein with alkaline phosphatase in order to evaluate the effect of altering 
the casein composition of an artificial milk micelle; incorporation of partial or complete 
dephosphorylated p-casein had an adverse result on coagulation and syneresis. 
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There is relatively little information with regards to kinetic studies of 
dephosphorylation of casein. Bingham et al. (1976) assessed the effect of varying a s )-
casein concentration on potato acid phosphatase activity; results indicated that phosphate 
groups are competitive inhibitors of this enzyme. Additionally, kinetic constants were 
determined for the dephosphorylation of as)-casein at pH 7 and p-nitrophenyl phosphate 
as substrates. The Vmax value for as)-casein was seven-fold lower than that of Vmax for p-
nitrophenyl phosphate, while the Km values for both substrates were similar. West & 
Towers (1976) studied a phosphate transfer reaction through kinetics of 
dephosphorylation of a phosphopeptide derived from ~-casein, containing a cluster of 
phosphate groups, by bovine spleen phosphoprotein phosphatase; results indicated that 
the phosphate groups were removed in a sequential manner; the rate constants were 
calculated for each dephosphorylation stage indicating an enhancement of the activity of 
the phosphate cluster in transferring phosphate. 
2.4 Biological Properties of Caseins 
The understanding of the biological role of the caseins is required beyond their 
nutritional functions, especially since caseins are widely used in numerous food 
ingredients. The biological effects of caseins related to case in proteolysis and 
allergenicity play important roles in the development of new food ingredients that 
decrease or mitigate adverse consequences. Modification of caseins without 
compromising their functional properties is considered important to reduce undesirable 
biological effects. 
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2.4.1 Proteolysis of Caseins 
Caseins are relatively easily digested in the intestine compared with many other 
food proteins (Bos et al., 2000); successive in vitro digestion of casein with pepsin and 
trypsin yields peptides that contain physiological and biological functions (Pihlanto-
LeppaHi et al., 1994). During the complete digestion process, before proteins reach the 
large intestine, a less specific digestion is required in the small intestine, carried out by 
pepsin, which is an aspartate protease occurring in the stomach with an optimum pH 2-7; 
further digestion is accompli shed by trypsin and chymotrypsin, which are serine 
proteases from the intestine with an optimum pH 7-9 (Schmelzer et al., 2004); these 
endopeptidases are not specific to a certain substrate, but are capable of cleaving almost 
any protein inside the peptide chain. 
Increasing attention has been placed on the extent of proteolysis, the type of 
enzymes used and the conditions for proteolysis. Several researchers have studied 
peptides, non-dephosphorylated and dephosphorylated products derived from hydrolysis 
with specific gastric proteases such as trypsin and chymosin (Visser et al., 1995; Lemieux 
& Amiot, 1989) using p-casein as model. Tryptic digestion of p-casein yields several 
important nutraceutic and nutritious peptides. However, a final peptide (1-105) product 
causes enzyme inhibition; Chobert et al. (1998) described a mutation replacement of 
LyS188 for aromatic amino acid residues that altered the specificity oftrypsin for c1eaving 
J3-casein in many places, hydrolyzing as weIl the fragment 1-105. Guillou et al. (1991) 
investigated the hydrolysis of pA2-casein by bovine chymosin and pep sin A to compare 
the hydrolysis of the two enzymes on this protein; several peptides were identified as weIl 
as the preferred c1eavage site for both proteases. The peptides produced from native and 
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dephosphorylated a-casein need also to be studied since a-casein is the major fraction 
present in bovine milk (Blanc, 1981). 
2.4.1.1 Proteolysis of Dephosphorylated Casein 
Phosphate removed enzymatically from casein serine residues pro duce protcins 
that possess unique and specific biological properties. Removal of sorne or most of the 
negatively charged phosphate groups from caseins cause a modification in the net casein 
charge and consequently, the flexibility and properties of the new modified casein 
structure are altered (Cassiano & Areas, 2003). The conformational change achieved by 
dephosphorylation may influence the effect of proteinases, altering the biological 
significance of the caseins. The high degree of case in phosphorylation may cause 
inhibition of certain digestive enzymes, leading to the formation and accumulation of 
longer peptides, which may negatively affect final organoleptic characteristics of cheese, 
and influence its final quality (Alli et al., 1998). Dephosphorylated case in hydrolysates 
have been used recently as nutritional food ingredients as they have shown to exert 
favorable digestive and metabolic effects on people suffering from severe gastrointestinal 
diseases (Maubois & Leonil, 1989). Additionally, curd or clot formation can influence 
digestion of case in, especially in infants; in vitro digestibility of modified caseins by 
gastrointestinal enzymes, demonstrated that dephosphory lated casein improved 
digestibility properties and acid clotting of bovine case in for infant feeding (Li-Chan & 
Nakai, 1989). Dephosphorylated caseins can find applications in the formulation of infant 
formulae in which rapid digestion by gastric enzymes is highly desirable (West, 1986). 
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2.4.1.2 Products of Casein Proteolysis 
Proteolysis of milk proteins to generate peptides has been practiced for a long 
time. Enzymatic modification of casein pro duces peptides and in sorne cases free amino 
acid residues (Kil ara & Panyam, 2003). The accumulation of hydrophobie peptides 
causes bitterness which is a common occurrence and problem in many chee se varieties 
(Singh et al., 2005). Sorne of the peptides in milk proteins are capable of affecting 
biological functions of an organism (Meisel et al., 2001); these biological effects may 
play an important role in the development of medical foods that treat or mitigate the 
effects of diseases and increase the nutraceutical aspects of foods containing case in 
peptides. Additionally, casein-derived bioactive peptides represent a source of health 
enhancing components that may be incorporated in functional foods and in 
pharmaceutical preparations. 
2.4.1.3 Bioactive Peptides 
A variety of food protein peptides has been demonstrated to elicit biological 
effects in various in vitro or in vivo test systems. These compounds from food proteins 
are known as biologically active peptides and are identified as digestion products of 
several food proteins. Bioactive peptides are absorbed intact and modulate digestion, 
appetite and endocrine metabolism by binding to specific receptors (Yamamoto et al., 
2003). 
Biologically active peptides derived from milk proteins are inactive within the 
sequence of the precursor proteins but can be released by enzymatic proteolysis. 
Bioactive peptides of milk prote in have been classified (Meisel, 2005) into four groups: 
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1) opiod agonist, including casomorphins, exorphins and u- and ~-lactorphins, 2) opiod 
antagonist (casoxins), 3) immunostimulants (immunopeptides) and 4) mineraI carriers or 
caseinophosphopeptides. The term opiod refers to morphine-like effects which include 
signs of sedation, tolerance, sleep induction and depression. Opiod receptors (Il-, ù- and 
K-type) are located in the nervous, endocrine, and immune system as well as in the 
gastrointestinal tract of the mammalian organism (Teschemacher et al., 1997). The 
common structural feature among exogenous and endogenous opiod peptides is the 
presence of a tyrosine residue at the amino terminal end (except in u-casein opiods) and 
the presence of another aromatic residue such as phenylalanine or tyrosine in the third or 
fourth position (Chang et al., 1981); this structural motif fits into the binding site of opiod 
receptors. A negative potential formed close to the phenolic hydroxyl group of tyrosine is 
essential for opiod activity. Even though bioactive peptides have already found 
interesting applications as dietary supplements and as pharmaceutical preparations; 
Garvey (2002) stated that peptides with opiod activity may cause or trigger autism. 
Autism being a syndrome with multiple nongenetic and genetic causes has been reported 
to increase 556% in pediatric prevalence between 1991-1997 (Muhle et al., 2004). 
Peptides with opiod activity are highly resistant to further hydrolysis by intestinal 
enzymes; once adsorbed into the blood, these peptides can pass to the brain and various 
other organs to elicit an opiod or morphine-like effect (Teschemacher et al., 1997). 
Food bioactive peptides from milk proteins are also claimed to be health 
enhancing components for functional foods that are used to reduce the risk of disease or 
to enhance a certain physiological function, even insignificant amounts of liberated 
peptides maybe sufficient to exert biological effects (Meisel et al., 2001). Many different 
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roles can be attributed to these peptides. Milk-derived casomorphins contribute to the 
regulation of nutrient assimilation by decreasing intestinal motility and improving 
digestion and absorption, particularly p-casomorphins (Froetschel, 1996); when released 
into the small intestine during the digestion of p-casein, these bioactive peptides are 
absorbed intact and inhibit gastrointestinal motility and the emptying rate of the stomach 
(Daniel et al., 1990). Moreover, p-casomorphins possess antidiarrheal effects which 
results from the enhancement of water and electrolyte absorption stimulated by the 
casomorphins. Several studies (Miguel et al., 2006; FitzGerald & Meisel, 2000) have 
demonstrated that casokinins and lactokinins sequences can inhibit the activity of 
Angiotensin-I-converting enzyme (ACE), which is involved in vasoconstriction of blood 
vessels, a part of blood flow regulation, this action has antihypertensive effects. 
Bioactive peptides are also related to bactericidal activity, especially lactoferricin 
derived from the whey iron-binding glycoprotein lactoferrin (Tomita et al., 1994). This 
peptide fragment (17-41) from lactoferrin is generated in vitro upon enzymatic digestion 
of lactoferrin with pep sin. The mode of action against micro-organisms is by increasing 
the cell membrane permeability (Strom et al., 2000). A casein derived peptide from K-
casein glycopeptide has the ability to protect against caries, since it inhibits viral of 
bacterial adhesion to oral surfaces (Brody, 2000). Several peptide fractions can affect 
immune functions by simulate phagocyte activity of macrophages that cause biochemical 
changes in the cell; when the phagocytic activity of immune cells increases, it conf ers 
protection against bacterial infections (Faith et al., 1984). 
Phosphopeptides can exert an influence on absorption in the intestine of calcium 
or other mineraIs induding iron, magnesium and zinc; casophosphopeptides can form 
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soluble organophosphate salts that work as mineraI carries (Sato et al., 1986). It wa~ 
found that the high number of phosphate residues present in asl-casein, aû-casein and p-
casein represent the binding site for these mineraIs (West, 1986). Yeung et al. (2001) 
reported that iron bound to casein phosphoserine clusters becomes less available for 
digestion unless successive digestion of case in with pep sin and trypsin yields peptides 
that can be dephosphorylated by intestinal alkaline phosphatase; hence the divaient 
metals bound can be accessible for absorption. 
2.4.1.4 Techniques for Identification of Products of Casein Proteolysis 
Three methods used to analyze casein peptides are: (i) electrophoretic techniques 
usmg polyacrylamide gels with urea (Pardo & Natalucci, 2002) or sodium 
dodecylsulphate (Janer et al., 2005), isoelectric focusing (Gauthier & Pouliot, 2003) and 
more recently two-dimensional gel electrophoresis (Mamone et al., 2003), (ii) high-
performance liquid chromatography (HPLC) by ion-exchange (Juillard et al., 1998) and 
especially reversed-phase modes (Lemieux & Amiot, 1989; Janssen et al., 1984) and (iii) 
immunological methods (Lv et al., 2003). Each method has its own advantages; however 
liquid chromatography has become a powerful tool, especially when coupled with mass 
spectrometry (Weber et al., 2006; Miquel et al., 2005). This technique has made possible 
to obtain major advances in the identification of peptides derived from milk proteins. 
2.4.1.4.1 Food Proteomics 
Proteomics is an area of molecular biology that is concerned with the systematic 
analysis of proteins. The proteome is a complex and dynamic entity that can be defined in 
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terms of the sequence, structure, abundance localization, modification, interaction and 
biochemical function of its components, providing a rich and varied source of data and 
information (Twyman, 2004). Post-translational modification either by cleavage of the 
polypeptide backbone, chemical or enzymatical modification of specific amino acids side 
chains increases the complexity of the proteome; therefore there is a need for techniques 
that allow the separation of protein mixtures into their individual components followed 
by characterization of the individual proteins or peptides (Kwon et al., 2006). 
Several bioanalytical techniques are currently used to solve emerging challenges 
associated with proteomics; they include two-dimensional polyacrylamide gel 
electrophoresis 2D-PAGE, electrospray ionization mass spectrometry (ESI-MS), matrix-
assisted laser desorptionlionization mass spectrometry time of flight (MALDI-TOF MS), 
tandem mass spectrometry (MS/MS) and liquid chromatography LC-MS/MS. 
Combination of these techniques can result in powerful tools to characterize post-
translational modification of proteins (Figure 2.4). MS is complementary to other protein 
and peptide analysis methods such as protein sequencing, amino acid analysis and high 
performance liquid chromatography peptide mapping. Additionally, it is particularly 
useful for identifying post-translational modifications which are quite difficult to 
distinguish by other methods; MS also can replace alternative methods for protein 
sequencing, such as Edman degradation (Jensen, 2004). 
2.4.1.4.2 Mass Spectrometry for Identification of Proteolysis Products 
Milk and derived peptides have been the subject of numerous MS investigations; 
these include identification of milk protein variants and glycoforms, fingerprinting, 
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degree of glycoforms and post-translational modification such as phosphorylation 
(Alomirah et al., 2000). Mass spectrometers are used to measure the mass-to-charge 
ratios (rn/z) of biological molecules, and then the rn/z values can be used to calculate 
molecular weight as well as determine primary sequence information when tandem mass 
spectrometry experiments are performed. MS can provide accurate molecular weights for 
peptides and proteins with masses up to 500 KDa using only few picomoles of sample 
(Calbiani et al., 2006); the accuracy achieved is better than 0.1 % of the calculated mass. 
Using MS/MS, complete or partial sequence information may be obtained at the 
femtomole level for peptides containing up to 25 amino acid residues (Speicher, 1996). In 
MS/MS two consecutive stages of mass analysis are used to detect secondary fragment 
ions that are formed from a particular precursor ion. Peptide fragment ions are produced 
in the mass spectrometer primary by cleavage of the amide bonds thatjoin pairs of amino 
acid residues (Koomen et al., 2005); two types of ions are formed: y (C-terminal charge 
retention) and b (N-terminal charge retention) as illustrated in Figure 2.5. Using a full 
series of one type of ion, the sequence of the entire peptide as well as post-translational 
modifications can by determined by the mass difference between fragments (Kuster & 
Mann, 1998). 
MS/MS can provide sequencing information even if the peptides are present in 
complex mixtures, and more importantly, even if they are modified (Carr et al., 1991). 
Moreover, it plays an important role in mapping dephosphorylation. Dephosphorylation 
of milk proteins produce a shi ft of 80 Da in the molecular mass of case in, which 
corresponds to the removal of HP03 - from the -OH group of a serine or threonine residue 
(Lund & Ardo, 2004). The importance of phosphorylation and dephosphorylation has 
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lead to the development of phosphoproteomics, which can de defined as the study of the 
phosphorylation state of proteins (McCormick et al., 2005). Recently, several methods 
have been developed and used to locate phosphorylation sites of peptides and proteins. 
Many of them employ the strategy of degrading the phosphoprotein either chemically 
(Jaffe et al., 1998) or enzymatically (Liao et al., 1994) into small peptides, followed by 
analysis of the composition and mapping of each fragment. Many examples of the 
application of mass spectrometry to identify phosphorylation sites have been published. 
Hunter & Games (1994) studied the use of LC-MS/MS for the identification of 
phosphorylation by neutral ion loss of phosphoric acid (H3P04) via gas-phase ~­
elimination of this ion (-98 Da) from phosphoserine and phosphothreonine residues of a 
tryptic digests of <Xsl-casein. Carr et al. (1996) characterized the lost of a phosphate 
group (-79 Da) and sequencing of serine, threonine and tyrosine phosphopetides by using 
LC-MS/MS under alkaline conditions in a negative-ion mode at femtomole level of 
prote in digests. Yip & Hutchens (1992) investigated the use of MALDI-TOF mass 
analysis to monitor protein and peptide phosphorylation and dephosphorylation reaction 
rates, even in complex unfractionated mixtures. 
The type of ion source used determines the types of ions that can be obtained 
during a mass spectrometry analysis. The most common ionization methods MALDI and 
ESI are widely used (Alomirahet al., 2000). In MALDI a solution containing the analyte 
is mixed with another organic solution containing the matrix, upon drying of the matrix a 
laser irradiates the matrix deposits and de sorbs the analyte molecules, producing ions that 
correspond to the protonated molecules of the analyte (Tanaka et al., 1988). In ESI-MS a 
solution containing the analyte is sprayed from a capillary by using a high voltage, 
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generating small drop lets in the gas phase which evaporate leaving multiply charged ions, 
in proteins and peptides these ions are multiprotonated (Whitehouse et al., 1985). 
2.4.1.4.3 Proteomics Database Analysis and Search Engines 
The availability of bioinformatics solutions is crucial for proteomics technologies. 
One of the most used strategies in proteomics is correlative database searching; this 
involves searching the sequence databases for proteins containing peptides that match 
experimental data obtained by mass spectrometry resulting in definitive prote in or 
peptide identification (Chalkley et al., 2005). Computer algorithms have been developed 
to use two different types of data; one approach involves collection of the molecular 
weight generated by protein digestibility after mass spectrometry analysis; thus the mass 
map fingerprint can be generated (Henzel et al., 1993). The second approach is based on 
the use of data created by tandem mass spectrometers; MS/MS spectra contain highly 
specific information in the fragmentation pattern as weIl as sequence information (Yates, 
1998). Several web sites offer free access to web-based database-searching programs for 
peptide mass fingerprinting and the identification of sequence tags, aIl of which provide 
other tools such as prediction of enzyme digests. Examples of databases include 
UniProtKB/Swiss-Prot provided by the Swiss Institute of Bioinformatics 
(http://us.expasy.org/tools/) and UniProtKB/TrEMBL provided by the European 
Bioinformatics institute (http://www.ebi.ac.uk/trembl/); which are available for protein 
sequences annotated for function, subcellular location and known potential post-
translational modifications. 
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Mascot is a search engine developed by the Imperial Cancer Research Fund, 
London, UK and Matrix Science Ltd., London, UK researchers, that incorporate3 
probability-based scoring (Perkins et al., 1999). It supports three types of search: i) 
peptide mass fingerprint, ii) sequence query and iii) MS/MS ion search. Mascot can be 
freely accessible across the World Wide Web at Uniform Resource Locator (URL) 
http://www.matrixscience.com. The fundamental approach of Mascot is to calculate the 
probability that the observed match between the experimental data seat and each 
sequence database entry is a chance event (Weber et al., 2006). In the case of MS/MS 
fragment ion data are matched to calculated values for user-selected ion series. The 
advantages of this search engine are based on probability and inc1ude a simple rule ta 
decide whether a result is significant or not and Mascot scores can be compared with 
those from other types of search like sequence homology (Perkins et al., 1999). 
Recently, a study to detect milk allergens in different food matrixes, involved the 
analysis of tryptic digest of casein by using Le-MS/MS and database analysis (Weber et 
al., 2006); MS/MS data from the mass spectrometry system were processed with 
specialized MS/MS software and submitted for database search using Mascot for prote in 
identification. This study demonstrated the capability of the MS/MS database se arch to 
provide reliable confirmation of the presence or absence of milk allergenic proteins. 
2.4.2 Casein Allergenicity 
Bovine milk is recognized as one on the mam food allergens. Milk allergy 
incidence ranges from 0.3 to 7.5% of newborn or young children (Kajosaari & Saarinen, 
1983) and less than 2% in adults (Stoger & Wuthrich, 1993). The multiplicity and 
diversity of proteins that are involved in milk allergy, inc1udes polysensitization to 
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several proteins (Sharma et al., 2001). Caseins appear to be the major allergens 
responsible for bovine milk allergy; among caseins, asl-casein is a major allergen in miik 
(Docena et al., 1996). Most patients allergie to casein are sensitized to the four casein 
fractions; this cosensitization to the different caseins likely occurs after disruption of the 
casein micelle during the digestive process; polysensitization also appeared to be due to 
cross-sensitization mechanisms and involved the regions that contain the major sites of 
phosphorylation (Wal, 2004). 
In healthy subjects, orally ingested milk proteins, induce antigen-specific 
systemic responsiveness, referred as oral tolerance (Juvonen et al., 1999). This 
phenomenon is well described in animal models; however, the real pathogenic 
mechanisms of allergenic reactions have been intensively studied over the last five years 
in order to increase the understanding of food-induced allergenic reactions (Sampson, 
2004). Food initially contact the gut mucosa and the allergenic symptoms spread outside 
the gastrointestinal tract, although Hsieh et al. (2003) demonstrated that food allergy can 
be also induced by allergen exposure through the skin. Milk proteins tend to stay intact 
as milk is converted to dairy products of all types (Besler et al., 2001), when caseins are 
ingested they may be absorbed into the blood fully undigested provoking an immune 
response and malabsorption, especially pronounced in infants (Savilahti, 2000). 
The above immune response occurs in two phases, an initial sensitization to an 
allergen followed by elicitation of an allergie reaction on subsequent exposure to the 
same allergen as shown in Figure 2.6 (US Food and Drug Administration; Threshold 
Working Group, 2006). Sensitization occurs when a susceptible individual produces IgE 
antibodies against specifie proteins found in food; re-exposure to the same food allergen 
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initiates binding of the allergenic proteins to IgE molecules on immune mediator cells 
(basophiles and mast cells), leading to activation of these mediator cells (Goldsby et al., 
2003); this elicitation causes the release of inflammatory molecules like leukotrienes and 
histamine. The specific symptoms and severity of an allergic reaction are affected by the 
concentration of allergen, route of exposure, and the organ systems involved, including 
skin, gastro intestinal tract, respiratory tract, and blood (Ebo & Stevens, 2001). 
2.4.2.1 Molecular Characteristics of Allergenic Structures of Casein 
Advances in technology have lead to allergenic maps sites for many food 
proteins. Immunoglobulin E (IgE) binding sites or epitopes on the allergenic protein may 
consist of segments of consecutive amino acids referred as sequential epitopes (e.g., 
caseins), or amino acids from different parts of the protein sequence (e.g., whey proteins), 
brought together by protein folding named conformational epitopes (Nowak-Wegrzyn, 
2003); they are represented in Figure 2.7. In milk proteins both types of epitopes might 
be responsible for allergenic reactions; they are both conformational and linear epitopes, 
widely spread all along the protein molecules (Wal, 2004). 
The phosphate groups of caseins bound to serine are present in the major epitopes 
regions that affect the IgE immunoreactivity of caseins, especially a homologous 
sequence present in a s!-, a s2- and B-casein, SerP-SerP-SerP-Glu-Glu, which is a highly 
conserved major site of phosphorylation (Wal, 2002). This sequence plays an important 
part in cross-reactivity, since it has already been described as immunoreactive (Bernard et 
al., 1998) and resistant to digestive degradation (Hynek et al., 2002). Bernard et al. 
(2000) determined that modification of such well-characterized site in case in affects their 
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immunoreactivity. Otani et al. (1987) evaluated that anti-native-casein antibody had a 
higher affinity to native caseins than to dephosphorylated caseins, suggesting that 
dephosphorylation affected the antigen-antibody reaction. 
2.4.2.2 Effect of Proteolysis on the Allergenicity of Caseins 
In the last few years, sensitivity to casein during the digestive process has 
increased in terms of both frequency and intensity of IgE response (Stoger & Wuthrich, 
1993); the potentially allergenicity of casein phosphopeptides should be taken into 
account when considering their biological interest and possible functional use in foods. 
After ingestion most of casein structure the potential antigens may be modified by gastric 
conditions, action of digestive enzymes and uptake through the intestinal mucosa (Otani 
et al., 1987). The major epitopes on usl-caseins are continuous epitopes located in the 
hydrophobic regions of the molecule, where they are not accessible to antibodies unless 
the case in is hydrolyzed during digestion (Chatchatee et al., 2001). Milk prote in 
hydrolysates, although frequently used as substitutes for milk proteins because of their 
allergenicity, show reduced but never complete absence of allergenicity (Caffarelli et al., 
2002). Hypoallergenic hydrolysates are widely used on the market for the treatment of 
children cow's milk allergy. However, sorne anaphylactic reactions have been 
experienced (Walker-Smith, 2003). The degree of hydrolysis necessary in infant 
hydrolysates formulae to obtain the desired reduction of allergenicity and what peptide 
fractions are responsible for this residual allergenicity in the hydrolysates are not yet 
known (Niggemann et al., 1999). The importance of peptide chain length on allergenicity 
has been reviewed. Otani et al. (1986) studied the allergenicity of asl-casein and sorne 
36 
peptides derived form this prote in, by using a combination of a chemical agent different 
fragments were obtained. Fragments 1-54,61-123,124-135 and 136-196 showed 19.4%, 
31.4%, 10% and 20.3% of antibody-binding activity, respectively. This indicates that one 
site for high antigenicity is found in the phosphorylated 61-123 fragment; these 
researchers also found that polar amino acids such as lysine, histidine and glutamic acid 
were important components of sorne antigenic reactive regions of usl-casein and ~­
casein. 
2.4.2.3 Techniques for Determining Casein Allergenicity 
Information about the epitopes of a protein can be obtained by several methods, 
including: i) evaluation of the antigenic properties of peptides resulting from enzymatic 
or chemical fragmentation of the protein, ii) epitope mapping carried out by 
immunological testing of synthetic of peptides according to the protein entire sequence 
and iii) epitope mapping based on a set of overlapping sequential peptides shifted by one 
amino acid (Spuergin et al., 1996). In vitro immunoenzymatic techniques like 
immunoblotting and Enzyme-Linked Immunosorbent Assay (ELISA) are widely used to 
detect the presence of residual allergenicity in food products. 
2.4.2.3.1 Immunoblotting 
The immunoblotting technique provides information about presence, molecular 
weight, and quantity of an antigen by combining protein separation via gel 
electrophoresis with specific recognition of antigens by antibodies (Goldsby et al., 2003); 
immunoblotting is useful when the antigen of interest is insoluble or readily degraded. 
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Since most gel electrophoresis procedures result in denaturation of the antigen, only 
polyclonal and monoclonal antibodies that recognize the denatured form of an antigen 
can be utilized in immunoblotting (Restani et al., 1996). 
2.4.2.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) 
ELISA detects the presence of an antibody or an antigen in the sample to be 
analyzed. It utilizes two antibodies, one of which is specific to the antigen and the other 
which is coupled to an enzyme (horseradish peroxidase or alkaline phosphatase). This 
second antibody causes a chromogenic or fluorogenic substrate to produce a signal 
(Rabin et al., 1992). ELISA can be a quantitative, rapid and dependable assay since many 
samples can be tested in paraUel. In the most common format an antigen is immobilized 
by adsorption to the weUs of a microtitre plate, and then reacted with the analyte. Three 
types of ELISA assays can be found: 1) Sandwich ELISA, 2) Direct ELISA and 3) 
Indirect ELISA (Figure 2.8). The most commonly used ELISA is the sandwich assay. 
The analyte to be measured is bound between two antibodies- the capture antibody and 
the detection antibody. The assay is then quantitated by measuring the amount of labeled 
second antibody bound to the matrix, through the use of a colorimetric substrate. The 
antigen does not need to be purified prior to use, and the assay is very specific. However, 
one disadvantage is that not aU antibodies can be used (Rabin et al., 1992). The direct 
detection method 1abe1ed antibodies with a fluorescent tag to mark tissue antigens. In this 
technique, a labeled primary antibody reacts directly with the antigen. Direct detection is 
not widely used in ELISA but is quite common for immunohistochemical staining of 
tissues and cells (Coons & Kaplan, 1950). The indirect method uses a labeled secondary 
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antibody for detection. First, a primary antibody is incubated with the antigen. This is 
followed by incubation with a labeled secondary antibody that recognizes the primary 
antibody (WeIler & Coons, 1954). For ELISA it is important that the antibody enzyme 
conjugate is of high specifie activity, this can be achieved when the enzyme conjugation 
hemistry preserves antibody specificity as weIl as enzyme activity (Goldsby et al., 2003). 
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CHAPTER3 
ENZYMATIC DEPHOSPHORYLATION OF BOVINE 
CASEIN 
3.1 Justification 
Enzymatic dephosphorylation of casein proteins is preferred over chemical 
dephosphorylation for many food applications. Enzymatic dephosphorylation results in 
release of phosphate groups leaving the dephosphorylated serine residue intact on the 
protein. Although there have been several studies on enzymatic dephosphorylation of 
caseins (Li-Chan & Nakai, 1989; Bingham et al., 1976), there is relatively little 
information on the kinetics of dephosphorylation of caseins. It is considered important to 
establish optimum dephosphorylation conditions of caseins before a detailed approach on 
products of dephosphorylation is performed. This chapter addresses the first research 
objective to enzymatically dephosphorylate whole casein and its a-casein and ~-casein 
fractions and to investigate the kinetics and extents of dephosphorylation. 
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3.2 Materials and Methods 
3.2.1 Materials 
Commercial dry skim milk powder was purchased and reconstituted with 
distilled water (370 g/l). Whole casein was precipitated with lM ammonium acetate 
buffer at 20 oC and pH 4.6. The case in was washed with acetone, air dried and stored in a 
desiccator until further analysis (Veloso et al., 2002). Commercial bovine u-casein and p-
casein standards and potato acid phosphatase (EC 3.1.3.2; activity: 1.2 units/mg solid) 
were purchased from Sigma Chemicals Co. (St.-Louis, MO); the u-casein was not 
separated further into its U s \- and u s2-casein fractions. 
3.2.2 Protein and Phosphorus Contents 
Total phosphorus was determined by dry-ashing (600 oC, 5 h; Furnatrol Il 
Furnace, Thermolyne Co, Iowa) followed by colorimetrie analysis (823 nm, Ultrospec 
100 UVNis; Biochrom Ltd., Cambridge, UK) using the method of Pulliainen & Wallin 
(1994). For measurement of free phosphate, the dry-ashing step was exc1uded; only the 
colorimetrie step was necessary. Protein content of whole casein and dephosphorylated 
whole casein was determined using the method of Lowry et al. as modified by Hartree 
(1972); bovine serum albumin was used as standard. 
3.2.3 Caseins Dephosphorylation 
3.2.3.1 Effect of Enzyme Concentration 
Dephosphorylation of whole casein with potato acid phosphatase was carried out 
using the method of Bingham et al. (1976) with modification (citrate buffer 0.1 M, pH 
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5.8, 37 OC). Controls were prepared using whole casein but without the addition of the 
enzyme. The enzyme reaction was performed in duplicate using enzyme concentrations 
of 0.05, 0.10, 0.15, 0.20 and 0.25 mg/ml; the total reaction mixture was 10 ml and 
contained 25 mg case in. The reaction was carried out at time intervals of 1 h for 4 h and 
stopped by the addition of 5 ml 15% trichloroacetic acid (TCA). The precipitated prote in 
was recovered by centrifugation (3,000 x g, 5 min) and analyzed for phosphorus content 
as described before in Section 3.2.2. 
3.2.3.2 Effect of Reaction Time 
Based on results from the preliminary experiment described in Section 3.2.3.1, an 
enzyme concentration of 0.2 mg solidlml was selected to investigate the effect of reaction 
time. The dephosphorylation reaction mixture was 10 ml and contained 25 mg who!c 
casein. It was carried out at time intervals of 1 h for 8 h and stopped by the addition of 5 
ml 15% TCA. The precipitated protein was recovered by centrifugation (3,000 x g, 5 
min) and analyzed for phosphorus content (Section 3.2.2). Optimum reaction time of 6 h 
for whole casein was determined and these final optimum conditions were used to 
dephosphorylate a-casein and p-casein. 
3.2.3.3 Effect of Substrate Concentration 
The effect of varying whole casein concentration (1.25, 2.5, 3.5, 5, 6.25, and 7.5 mg/ml) 
on dephosphorylation was determined. The reaction was carried out at intervals of 30 min 
for 2 h at 37 oC and stopped by the addition ofTCA (5 ml, 15%). The dephosphorylated 
whole case in was recovered by centrifugation (3,000 x g, 5 min,) and analyzed for 
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phosphorus content (Section 3.2.2). The activity of the phosphatase (~g P/ml released 
after dephosphorylation) vs. the reaction time for each casein concentration were plotted 
in order to determine the initial velocity of dephosphorylation (V) before 30% of 
bioconversion was obtained; it was expressed in ~mol P/ml min. The double reciprocal 
plot of these data was used to calculate the apparent kinetic parameters (V max and Km) 
using the Lineweaver-Burk linear equation (1934). 
3.3 Results and Discussion 
Protein and total phosphate content of whole casein were 94.6% and 0.8%, 
respectively and 92.3% prote in for dephosphorylated whole casein. The free phosphate 
before enzymatic dephosphorylation represented 7.7% of the total phosphate; this free 
phosphate may be due to the presence of indigenous phosphatases in milk. These results 
agree with the values reported by Fox and McSweeney (1998). 
3.3.1 Extent of Dephosphorylation 
Figure 3.1 shows the phosphate released from whole casem by potato acid 
phosphatase as a function of incubation time. As enzyme concentration increased, the 
extent of dephosphorylation increased as the incubation time is extended. Highest 
dephosphorylation (65.4%) was obtained at an incubation time of 4 h at enzyme 
concentration of 0.2 mg/ml. For enzyme concentration of 0.25 mg/ml relatively low 
dephosphorylation of34.8% could be related to low enzyme solubility. 
44 
70 
s:::: 60 
0 
.-
.., 
50-ns 
-~ 
0 40 
..c 
c. 
tn 30 0 
..c 
c. 
Cl) 20 c 
~ CI 10 
0 ---I~------- -1 
0 1 2 3 4 5 
Time (h) 
Figure 3.1: Phosphate released from whole casein by potato acid phosphatase as a 
function of incubation time. Enzyme concentration: 0 0.05 mg/ml, • 0.10 mg/ml, !:J. 
0.15 mg/ml,. 0.20 mg/ml and X 0.25 mg/ml 
45 
Figure 3.2 shows the phosphate released from whole casein (2.5 mg/ml) as a 
function of incubation time with a selected enzyme concentration of 0.2 mg/ml. At 6 h 
and 8 h, 71.6% and 74% of dephosphorylation occurred, respectively. Optimum 
dephosphorylation conditions can be considered at 6 h; an increase of approximate 2.4% 
of dephosphorylation of whole case in was observed between 6 and 8 h. Figure 3.3 
demonstrates that u-casein (2.5 mg/ml) was dephosphorylated at 89.2% and ~-casein (2.5 
mg/ml) was 73.7% dephosphorylated. Previous work by Bingham et al. (1976) showed a 
maximum dephosphorylation of approximately 70% for usl-casein at pH 7 and 38 oC. Li-
Chan et al. (1989) reported 97%, 70% and 99% of dephosphorylation for whole casein, 
usl-casein and ~-casein, respectively. Other researchers (van Hekken & Strange, 1993) 
obtained 40% partially dephosphorylated whole case in at pH 6.5, 37 oc. The different 
extents ofdephosphorylation reported in other studies could be related to phosphate end-
product inhibition; Bingham et al. (1976) suggested that phosphate is a competitive 
inhibitor of potato acid phosphatase activity. Additionally, ~-casein with three 
phosphoseryl residues can resist the action of phosphatase; this resistance was attributed 
to intermolecular interactions involving the phosphate groups (West & Towers, 1976). 
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3.3.2 Kinetics of Dephosphorylation 
Figure 3.4 A shows the effect of varying whole casem concentration on 
dephosphorylation. The results indicate a linear relationship between casein concentration 
and dephosphorylase activity over the range of substrate concentration studied. The 
double reciprocal plot (Figure 3.4 B) was used to calculate the apparent kinetic 
parameters for whole casein; the values for the apparent Vmax and apparent Km were 0.283 
/lmol P/mg casein min and 9.951 mg caseinll, respectively. Bingham et al. (1976) 
reported kinetics parameters on1y for <Xsl-casein which cannot be compared with those 
obtained for whole casein; these researchers did not report inhibition data for whole 
casein because of the difficulty of measuring phosphate released from whole case in in the 
presence ofKH2P04 as inhibitor. 
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CHAPTER4 
MOLECULAR CHARACTERISTICS OF PRODUCTS 
FROM DEPHOSPHORYLATION OF BOVINE CASEINS 
4.1 Justification 
Relatively little information on the identification of the dephosphorylated casein 
species can be found; hence there is a need to study in detail the products of the 
enzymatic dephosphorylation reaction of caseins, in order to clearly identify the 
molecular changes occurring in the caseins molecule during dephosphorylation. The 
work described in this chapter addresses the second research objective related to the 
investigation of molecular characteristics of products of dephosphorylation using a 
combination of PAGE (urea and SDS), RP-HPLC and ESI-MS. 
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4.2 Materials and methods 
4.2.1 Materials 
Whole case in was obtained as described previously in Section 3.2.1. 
Commercial bovine a-casein and p-casein standards and potato acid phosphatase (EC 
3.1.3.2; activity: 1.2 units/mg) were purchased from Sigma Chemicals Co. (St. Louis, 
MO). The a-casein was not separated further into its asl- and a s2-casein fractions. 
Chemicals of electrophoretic and HPLC grade were used. Dephosphorylation of caseins 
was conducted as described in Section 3.2.3. 
4.2.2 Electrophoresis 
Whole casein, a-casein and p-caseins and their dephosphorylated products were 
subjected to slab gel polyacrylamide gel electrophoresis (PAGE) in the presence of 
sodium dodecyl sulfate (SDS) (Laemmli, 1970), using a Bio-Rad Miniprotean® II dual 
slab cell electrophoresis unit (Richmond, CA). The conditions used were: staking and 
separation gel 4% and 12% acrylamide, respectively and sample injection volume of 20 
III in the gels. Estimation of molecular weight was done by SDS-PAGE broad range 
molecular weight standards (Bio-Rad Hercules; CA). Slab gel at constant cUITent, 15 
mA/gel; run time approximately 2 h. After electrophoresis, gels were fixed for 1 h in a 
mixture of methanol (20% v/v) and acetic acid (10% v/v). Coomassie Brilliant Blue R-
350 (0.1 % w/v in fixing solution) was used to stain protein bands. Destaining was done 
using the fixing solution. Urea-P AGE was performed to achieve complete separation of 
whole casein, a-casein and p-casein (Coker, 1991). The conditions used were: 6% and 
20% acrylamide, respectively. Sample injection volume was 20 III in the gels. Slab gel at 
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constant voltage, 100 volts/gel; run time approximately 1.5 h. Prote in bands were stained 
with Coomassie Brilliant Blue R-350 (0.1 % w/v in fixing solution). Destaining was done 
using the fixing solution. 
4.2.3 Reverse-Phase High Performance Liquid Chromatography 
RP-HPLC was used to separate caseins and their dephosphorylated products with 
a liquid chromatograph (Beclanan; CA, US) equipped with a Programmable Solvent 
Module (model 126) for high pressure solvent delivery, a manual injector (20 Jllloop), a 
Programmable Detector Module (modelI66) and an Ultra C4 reverse phase column 5Jlm, 
250 X 4.6 mm colurnn (Restek Co., US). Chromatographie data were analyzed by the 
Gold System (version V810), translated into PRN format for Microsoft Excel© 
manipulation. Gradient elution was carried out with a mixture of two solvents. Solvent A 
consisted of 0.1 % trifluoracetic acid (TF A) in water and solvent B was 0.04% acidified 
water (TF A) in acetonitrile. Elution was performed at a flow rate of 1 ml/min with a 50 
min linear gradient starting at 25% of solvent Band increasing up to 45% of solvent B 
over 40 min, then the linear conditions were re-established over 10 min (Bernard et al., 
2000); detection was at 220 nm. Fractions eluting from the column were collected by 
Water Fraction Collector (NE, US), then pooled and concentrated, freeze-dried and stored 
at room temperature for further analysis. 
4.2.4 Electrospray Ionization Mass Spectrometry 
a-casein and p-casein standards were dissolved in 10% acetic acid and subjected 
to ESI-MS directly. For the controls (incubated without phosphatase), dephosphorylated 
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a-case in and dephosphorylated p-casein, dialysis against distilled water (4 OC) was used 
to remove buffer salts that can suppress the analyte signal during the electrospray 
ionization. A Waters Micromass QTOF Ultima Global (Micromass; Manchester, UK) 
hybrid mass spectrometer equipped with a nanoflow electrospray source was used. It was 
operated in positive ionization mode (+ESI) at 3.80 kV; with source temperature of 80 oC 
and desolvation temperature of 150 oC. The TOF was operated at an acceleration voltage 
of 9.1 kV, a cone voltage of 100 V and collision energy of 10 eV (for MS survey). For 
the MS survey mass range, m1z was 400-1990, scanned continuously over the 
chromatographic run. The mass spectrometer was tuned and calibrated with [Glu]-
Fibrinopeptide B (Sigma Chemicals Co.). Instrument control and data analysis were 
carried out by MassLynx V4.0 software (Waters Corporation, 2005). 
4.3 Results and Discussion 
4.3.1 Effects of Dephosphorylation on Molecular Characteristics 
Figure 4.1 shows the SDS-PAGE patterns for whole casein, a-casein and p-casein 
standards, controls (whole casein, a-casein and p-casein incubated without phosphatase), 
and dephosphorylation products of the caseins; the controls allowed us to determine if 
experimental incubation conditions affected the casein fractions in the absence of the 
phosphatase enzyme. No attempt was made to estimate molecular weights for the caseins 
because of the known anomalous behavior of caseins in SDS-PAGE (Creamer & 
Richardson, 1984). The identification of the casein fractions was done by comparison of 
migration distance with those of the known standards. The high intensity band of whole 
case in standard (lane 2) indicates that it was not separated into its individual a-casein 
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Figure 4.1: SDS-PAGE electrophoretic patterns of caseins. (1) Standards, (2) whole 
casein standard, (3) control whole casein, (4) dephosphorylated whole casein, (5) 0.-
casein standard, (6) control a-casein, (7) dephosphorylated a-casein, (8) ~-casein 
standard, (9) control ~-casein and (10) dephosphorylated ~-casein. (Controls: 
incubated without phosphatase) 
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and ~-casein fractions as their theoretical individual molecular weights are very similar 
(23.6 KDa, asl-casein, 24 KDa ~-casein; Farrell et al., 2004). Lane 4 shows 
dephosphorylated whole case in with two bands which are likely the separateù 
dephosphorylated a-casein and ~-casein fractions (comparison with whole casein, lanes 2 
and 3). The differences between the control and the phosphatase incubated a-casein 
(lanes 6 and 7) and p-casein (lanes 9 and 10) reflect the effect of dephosphorylation of 
these fractions. The SDS-PAGE results suggest changes in structures of a-casein (lanes 5 
and 6) and p-casein (lanes 8 and 9) in the absence of the phosphatase (control); however, 
there was no change in the structure of whole casein in the absence of the phosphatase 
(lanes 2 and 3). 
Figure 4.2 shows the urea-PAGE patterns for whole casein, a-casein and p-casein 
standards, controls (whole casein, a-casein and ~-casein incubated without phosphatase), 
and dephosphorylation products of the caseins. For whole casein standard (lane 1) and 
whole casein control (no phosphatase, lane 2), two intense bands corresponding to a-
case in and p-casein were observed. Urea-PAGE separated the casein fractions present in 
whole casein that was not obtained with SDS-PAGE. For dephosphorylated whole casein 
(lane 3), the two main bands were identified as dephosphorylated a-casein and 
dephosphorylated ~-casein; the migration of the dephosphorylated casein fraction is 
reduced as a result of the removal of the negative charge of the phosphate group (Li-Chan 
& Nakai, 1989). The presence of several bands with a-casein (lane 6) and p-casein (lane 
9) suggests that proteolysis also occurred during dephosphorylation in the presence of 
phosphatase. The differences between the control and the phosphatase incubated a-casein 
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Figure 4.2: Urea-PAGE electrophoretic patterns of caseins. (1) Whole casein 
standard, (2) control whole casein, (3) dephosphorylated whole casein, (4) a-casein 
standard, (5) control a-casein, (6) dephosphorylated a-casein, (7) J3-casein standard, 
(8) control J3-casein and (9) dephosphorylated J3-casein. (Controls: incubated 
without phosphatase) 
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(lanes 5 and 6) and p-casein (lanes 8 and 9) reflect the actual effect of dephosphorylation 
of these fractions; these effects were also evident with SDS-PAGE (Figure 4.1). Urea-
PAGE also suggested that proteolysis occurred in the control experiments (incubation 
without phosphatase) with a-casein (lane 5) and p-casein (lane 8). Li-Chan & Nakai 
(1989) also reported that both proteolysis and dephosphorylation of asl-casein occurred 
in the presence of an alkaline phosphatase. It is likely that the observed proteolysis in the 
a-casein and p-casein controls (no phosphatase) was the e'ffect of the incubation 
conditions on these proteins. Swaisgood (1982) reported that a-casein and p-casein 
showed greater susceptibility to proteolysis when they were separated from the casein 
micelle. Additionally, a-casein and p-casein exhibit more chain flexibility than typical 
globular proteins, which increases susceptibility to hydrolysis (Church et aL, 1981). 
Figure 4.3A shows the RP-HPLC chromatograms for whole case in standard (1) 
and dephosphory1ated wh01e casein (II). From the chromatogram of wh01e casein, the 3 
peaks were assigned as the K-casein, a-casein and p-casein fractions; the identities of 
these fractions were confirmed by SDS-PAGE (Figure 4.3B) and urea-PAGE (Figure 
4.3C). Bobe et al. (1998) reported similar elution pattern for the three casein fractions 
from whole casein. The RP-HPLC results showed slight changes in the retention times of 
the a-casein and p-casein as a result of the dephosphorylation. Removal of the phosphate 
groups is expected to increase hydrophobicity of the casein fractions, compared with the 
fully phosphorylated caseins (Strange et al., 1991; Bernard et al., 2000). 
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Figure 4.3: (A) RP-HPLC chromatograms of (1) standard whole casein and (II) dephosphorylated whole caseine Peak identity: 
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Figure 4.3: (B) Casein profiles obtained by SDS-PAGE. Fractions collected from 
RP-HPLC separation. (1) Standards, (2) k-casein, (3) a-casein, (4) p-casein, (5) 
dephosphorylated k-casein, (6) dephosphorylated a-casein and (7) 
dephosphorylated p-casein. 
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Figure 4.3: (C) Casein profiles obtained by urea-PAGE. Fractions collected from 
RP-HPLC separation. (1) Whole casein standard (2) k-casein, (3) a-casein, (4) ~­
casein, (5) dephosphorylated k-casein, (6) dephosphorylated a-casein and (7) 
dephosphorylated ~-casein 
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Figure 4.4A shows the chromatograms for a-casein standard (I), control a-casein 
(II) and dephosphorylated a-casein (III). a-casein was observed as a major peak with 
retention time of 31.9 min. The chromatogram of the control a-casein (no phosphatase, 
Figure. 4.4A, II) also gave the a-casein peak at 31.9 min, as well as several peaks which 
could be hydrolysis products of the a-casein; these results support our findings from 
electrophoretic analysis, which suggested that incubation conditions in the absence of the 
phosphatase resulted in sorne proteolysis of a-casein and p-casein. Dephosphorylated a-
casein (Figure 4.4A, III) gave a major peak at 32.3 min; it is likely that this shift in 
retention time from 31.6 min is due to the increased hydrophobicity of the 
dephosphorylated a-casein (Bernard et al., 2000). Figure 4.4B shows the chromatogram 
for p-casein standard (1), control p-casein (II) and dephosphorylated p-casein (III). The 
p-casein standard was observed as a doublet peak likely due to self-association of this 
case in (Bobe et al., 1998) with retention time 34.6 min. Control p-casein (no 
phosphatase, Figure 4.4B, II) shows the p-casein peak at 34.6 min as well as several 
peaks which could be hydrolysis products of the p-casein; similar observations were 
made from the previous in electrophoretic analysis. Dephosphorylated p-casein showed 
several overlapping peaks in the retention time range of 34.8 and 36.7 min. It is likely 
that these peaks represent dephosphorylated p-casein and dephosphorylated hydrolysis 
products of p-casein; similar results were observed with dephosphorylated a-casein. 
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Figure 4.5 shows the mass spectra and deconvoluted spectra of standard a-casein 
(A, B), incubated (no phosphatase) a-casein (C, D) and dephosphorylated a-casein (E, 
F). Using ESI-MS data to identify dephosphorylation in proteins, it can be expected that a 
mass decrease of 80 Da will be observed for removal of each phosphate group 
(Hirschberg et aL, 2004); with ESI tandem MS of phosphopeptides, loss of a phosphate 
group results in a decrease of 98 Da from a phosphoserine residue (Lund & Ardo, 2004). 
However, in this particular work a difference of 80 Da is considered since 
dephosphorylation with acid phosphatase leaves intact the serine residue and only HP03-
is removed. MS techniques have been used to identify the presence of phosphate groups 
in .phosphoproteins and in phosphopeptides resulting from enzymatic or che mi cal 
degradation of the phosphoproteins (Lee et aL, 2001; Zhong et aL, 2004). MW species 
corresponding to removal of phosphate groups form a-casein are identified in Table 4.1; 
in addition MW species not assigned to removal of phosphate but present both in the 
incubated (no phosphatase) and dephosphorylated a-caseins are identified as products of 
hydrolysis. Standard a-casein gave a MW of 23 612 Da; this compares well with both the 
theoretical MW of asl-casein B variant (23 618 Da) ca1culated from the cDNA sequence 
as reported by Stewart et al. (1984) and the observed MW (23614 Da) reported by Léonil 
et al. (1995). 
On the basis of comparison of expected MW from theoretical dephosphorylation 
of a-casein and observed MW from the dephosphorylated a-casein (Table 4.1), six 
dephosphorylated species (MW 23 536,23 458, 23 287, 23 140,23 050 and 22 975 Da) 
were identified, corresponding to 10ss of 1, 2, 4, 6, 7 and 8 phosphate groups during 
dephosphorylation. Four of the phosphoseryl residues occur at the Ser64- Ser68 region of 
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dephosphorylated a-casein 
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Table 4.1: Molecular species of a-casein, and dephosphorylated a-casein after 
deconvolution of mass spectra 
in a-
casein 
standard 
(Da).u 
23612* 
r-
a-casein after 
dephosphory lation 
(Da) 
Observed MW in a-
casein incubated 
(Da) 
Observed MW in 
a-casein 
dephosphorylated (Da) 
* Theoretical molecular weight of asl-casein B 23 618 Da (Stewart et al., 1984) 
Reason 
69 
the usl-casein molecule, with three of the phosphates on adjacent serine residues but 
separated from a fourth by a single Ile65 residue; the other four serilphosphates are 
distributed in the remainder of the molecule (Ng-Kwai-Hang, 2003). The control u-
case in (no phosphatase) showed the presence of the original u-casein (MW 23 618), as 
well as MW species (MW 23 534 and 23 459 Da) corresponding to loss of 1 and 2 
phosphate groups respectively; this suggests partial dephosphorylation of a-casein in the 
absence of added phosphatase; Léonil et al. (1995) also observed with ESI-MS, the 
occurrence of partially dephosphorylated casein with the loss of 1 phosphate group in the 
absence of added enzyme. Figure 4.6 shows the mass spectra and deconvoluted spectra of 
standard ~-casein (A, B), incubated (no phosphatase) ~-casein (C, D) and 
dephosphorylated ~-casein (E, F). Table 4.2 shows the MW species identified from these 
spectra. MW species corresponding to removal of phosphate groups from ~-casein are 
summarized in Table 4.2; in addition MW species not assigned to removal of phosphate 
but present both in the incubated (no phosphatase) and dephosphorylated ~-caseins are 
identified as products of hydrolysis. Standard ~-casein gave a MW of 24 017 Da, which 
compares weIl with the values of 24 024 Da and 24 028 Da reported for variant A 1_5P 
(Jimenez-Flores et al., 1987; Swaisgood, 1992). On the basis of comparison of expected 
MW from theoretical dephosphorylation of ~-casein and observed MW from the 
dephosphorylated ~-casein (Table 4.1), five dephosphorylated species (MW 23 942, 23 
855, 23 774, 23 687 and 23 615 Da) were identified, corresponding to loss of l, 2, 3, 4 
and 5 phosphate groups during dephosphorylation. West & Towers (1976) reported that 
dephosphorylation of ~-casein was non-random with an alkaline phosphatase from E. 
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Figure 4.6: (A) ESI-MS spectra of ~-casein standard indicating the net charge of the 
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Table 4.2: Molecular species of ~-, and dephosphorylated ~-casein after 
deconvolution of mass spectra 
23855 (-162) 
1 Dephosphorylation 
. ( -1 Phosphate) 
Dephosphory lation 
(-2 Phosphates) 
* Theoretical molecular weight of ~-casein 24 024 Da (Jimenez-Flores et al., 1987) 
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coli, but was different from the action observed with a bovine spleen phosphatase. The 
control p-casein showed the presence of the original p-casein (MW 23 023 Da), as 
well as a MW species of 23 852 Da corresponding to loss of 2 phosphate groups; this 
suggests partial dephosphorylation of p-casein in the absence of added phosphatase. 
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CHAPTER5 
EFFECTS OF DEPHOSPHORYLATION ON PROTEOLYSIS OF 
CASEINS: PEPTIDE IDENTIFICATION AS PRODUCTS OF 
PROTEOLYSIS 
5.1 Justification 
The products of enzymatic dephosphorylation of caseins were identified m 
chapter four; dephosphorylated caseins were identified by ESI-MS. The effects of 
dephosphorylation on proteolysis of the caseins was the next step of this study. Food 
proteomics is an emerging field in biological sciences. Most proteins, like caseins, 
undergo post-translational modifications such as phosphorylation. Knowledge of these 
modifications is important because they may alter casein properties, inc1uding stability, 
activity, and consequently, function of the casein. Proteomics has become a useful tool to 
analyze biological samples;' it uses mass spectrometry extensively to identify and 
characterize proteins (Chalkley et al., 2005). Caseins are relatively simple molecules to 
manipulate; protein digestibility and enzymatic modification methods were used to 
determine the effect of phosphate groups on biological properties. In addition, novel mass 
spectrometric peptide sequencing coupled with database analysis are emerging 
technologies for investigating casein modifications. 
This part of the study addresses the third research objective related to the effect of 
dephosphorylation on the hydrolysis of u- and ~-caseins. The identification and 
characterization of LC-ESI-MS/MS peptide mass mapping for the in vitro enzymatic 
hydrolysis simulating human gastric conditions is also described. 
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5.2 Material and Methods 
5.2.1 Materials 
Whole casein was obtained as described previously in Section 3.2.1. 
Commercial a-casein and ~-casein standards, potato acid phosphatase (EC 3.1.3.2; 
activity: 1.2 units/mg), pep sin from porcine stomach mucosa (E.C. 3.4.23.1; activity 3, 
600 units/mg prote in) and trypsin Type IX-S from porcine pancreas (E.C. 3.4.21.4; 
activity 16, 100 units/mg prote in) were purchased from Sigma Chemicals Co. (St. Louis, 
MO). MS reagents were HPLC grade. 
5.2.2 Enzymatic Dephosphorylation 
Dephosphorylation of caseins was conducted as described in Section 3.2.3 with a 
modification; in order to obtain adequate quantities of dephosphorylated caseins, the 
enzyme reaction was performed in 100 ml of citrate buffer containing 250 mg of different 
caseins and phosphatase concentration of 0.20 mg/ml. The reaction time was 6 h and it 
was stopped by lowering the temperature to 0 oC. Caseins were dialyzed ovemight 
against distilled water at 4 oC to remove salts from the buffer. Desalted samples were 
freeze-dried for further analysis. Controls (no phosphatase enzyme) were prepared under 
the same experimental conditions. 
5.2.3 Enzymatic Digestibility of Dephosphorylated Caseins 
In vitro proteolysis simulating human gastrointestinal conditions of native and 
dephosphorylated caseins was performed using the method of (Pihlanto-Leppala et al., 
1994) with an enzyme/substrate ratio of 1:100. 0.3% (w/v) solution of freeze-dried 
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caseins in (i) 10 mM HCI at pH 2 were prepared for peptic hydrolysis, and (ii) 10 mM 
phosphate buffer at pH 8 for tryptic hydrolysis. 0.1 % (w/v) solutions of pepsin or trypsin 
in distilled water were prepared; the enzyme-substrate mixture was incubated for 3 h at 
37 oC and the reaction was stopped by reducing the temperature to 0 OC. For combined 
proteolysis with pep sin and trypsin, initial conditions were set at pH 2; after 1.5 h the 
reaction was adjusted to pH 8 and then trypsin solution was added to the reaction 
mixture. Substrate and enzyme solutions were prepared immediately before the 
hydrolysis experiments. Controls (native and dephosphorylated (X- and ~-casein) were 
performed without the addition of pep sin and trypsin enzymes. 
5.2.4 Peptide Analysis 
5.2.4.1 Reverse-Phase High Performance Liquid Chromatography 
The products form proteolytic hydrolysis of caseins and the dephosphorylated 
caseins were subjected to RP-HPLC. The analysis was carried out as described in Section 
4.2.3. An octadecyl (CI8) reverse phase 51lm, 250 X 4.6 mm column (Mallinckrodt 
Baker, Inc.; New Jersey, USA) was used. Solvent A consisted of 0.1% TFA in water and 
solvent B was 60% acetonitile/40%water/0.l % TF A acidified water (TF A) in acetonitrile 
(Pihlanto-LeppaHi et al., 1994); elution was performed at a flow rate of 0.8 ml/min with a 
60 min linear gradient starting at 0% of solvent Band increasing up to 80% over 50 min, 
then the linear conditions were re-established over 10 min. Detection was carried out at 
215 nm. 
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5.2.4.2 Liquid Chromatography Electrospray Ionization Mass 
Spectrometry and Tandem Mass Spectrometry 
Hydrolyzed a-casein and ~-casein and their dephosphorylated hydrolyzed 
products were dialyzed, lyophilized and dissolved in 0.1 % formic acid. Controls (no 
proteolytic enzymes) were subjected to the same procedure. Samples were analyzed by as 
described in Section 4.2.4. For LC-MS/MS analysis, the mass spectrometer was coupled 
to a Waters CapLC system, operated at a flow rate of 6 ~l/min. A splitter placed before 
the column delivered a final flow rate of 0.3 ~l/min. The guard column consisted of 
Waters Symmetry 300 NanoEase C18, 5 ~m. The separation was achieved using a 
Waters Atlantis dC18, 3 ~m, 75 ~m x 50 mm column. A binary gradient of solvent B 
(acetonitrile: 0.1% formic acid) and solvent A (water: 0.1% formic acid) was increased 
from 5 to 50% in 25 min. Injection volume was 5 ~l. For the MS survey mass range, m/z, 
was 400-1990 and for MSIMS was 50-1990, scanned continuously over the 
chromatographic run (Waters Corporation Manual, 2005). The mass spectrometer was 
tuned and calibrated with [Glu]-Fibrinopeptide B (Sigma Chemicals Co; St. Louis, MO). 
Instrument control and data analysis software were carried out by MassLynx V4.0 and 
ProteinLynx Global Server 2.1 (Waters Corporation, 2005). MS data analysis was carried 
out by MassLynx V4.0 software. 
5.2.4.3 Database Analysis 
Evaluation of the effect of dephosphorylation on proteolysis and peptide 
sequences characterization was achieved using the survey MS/MS data; two softwares 
were used: ProteinLynx Global Server v2.1 (Waters Corporation, 2005) and Mascot 
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(Perkins et al., 1999). ProteinLynx is an integrated software used for protein and peptide 
identification and inc1udes a database search engine. The survey data acquired were 
processed by ProteinLynx to create a peak list (Appendix 1), which contained the MS/MS 
data to be searched against a F ASTA-formatted protein databank (SwissProt protein 
database, Swiss Institute of Bioinformatics, 2006); the factors contributing to the 
database search scores in ProteinLynx were the number of entries in the database, the 
mass accuracy, and the peak intensity. For the MS/MS scoring, every precursor mass in 
the query was compared to the mass of each theoretically determined peptide in the 
database, taking into account the tolerance of the precursor mass and the fragmentation 
characteristics. The probability for each identified peptide was then calculated and given 
a score, which were reported as natural logs. For instance, in a database with 100000 
entries, the maximum score would be 11.5 and the 95% significance threshold would be 
Il.4. The created peak list (Appendix 1) from ProteinLynx was transformed into PKL 
format and analyzed using the software search algorithm Mascot in the mode MS/MS Ion 
Search. The searches were not taxonomically restricted. The enzyme entry was set as 
pep sin, trypsin or none, according to each raw data set analyzed. The scoring of Mascot 
incorporated a probability-based implementation of the Mowse algorithm with the 
formula: Mowse score = - 10 X log (p); this score is based on the probability (P) that a 
peptide identified from the experimental fragment matched a peptide in a protein 
database. A random match will have a high probability (thus, a low Mowse score), 
whereas a valid match will have a low probability and consequently a high Mowse score. 
Mascot ranks the quality of the peptide matches and sums the scores of detected peptides 
to calculate a total protein score (Appendix 2). In order to eliminate ambiguous peptide 
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mass results, the results obtained from Mascot, with a score indicating peptide identity, 
were correlated by comparison of the fragmentation spectra obtained by ProteinLynx. AlI 
peptides masses were obtained as monoisotopic masses. The softwares (Mascot and 
ProteinLynx) used to process the MS/MS raw data were able to detect signal peaks within 
a speed time of approximately 10 sec. Additionally, these mechanisms were capable of 
using information hidden in low peaks that otherwise could not been distinguished from 
noise, allowing to considerably improve the identification rate and sequence coverage of 
the caseins. 
5.3 Results and Discussion 
5.3.1 Peptide Mapping by RP-HPLC 
Figure 5.l shows the RP-HPLC chromatographic patterns of (l-casem and 
dephosphorylated a-casein casein obtained after treatment with (A) pepsin, (B) trypsin 
and (C) combined proteolysis. Comparison of the chromatograms in Figure 5.1 for native 
and dephosphorylated a-casein indicates that many peptides are common to every 
enzymatic digests since they eluted at the same retenti on time (8-45 min), only slightly 
differences were noted in sorne peaks for dephosphorylated a-casein indicated an 
increase in retenti on time due to change in hydrophobicity obtained by the removal of 
phosphate groups. These results agree with those reported by other researchers (Lemieux 
& Amiot, 1990; Caries & Ribadeau Dumas, 1986). The pepsin treatment produced 
peptides mainly in a retention time range of 18-43 min whereas trypsin treatment 
generated diverse peptides at different retenti on times (8-48 min) compared to the peptic 
hydrolysis. The effects of both proteases produced a mixture of peptides over a wider 
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Figure 5.1: Chromatographie peptide mapping of (1) a.-easein and (2) dephosphorylated a.-easein after: (A) pepsin, (B) trypsin 
and (C) eombined pepsin-trypsin proteolysis 
retention time range (5-48 min). Peptides that eluted at the first part of the gradient are 
likely more polar and less strongly adsorbed; short hydrophilic peptides with basic 
character are poorly absorbed and have minor interaction with the column support 
(Janssen et al., 1984). Retention time of peptides on a reversed-phase column has beell 
shown to depend on their amino acid composition, ionization state, the localization of 
charges and the hydrophobicity rather than in the amino acid sequence (Lemieux & 
Amiot, 1989). 
Figure 5.2 represents the elution patterns of P- and dephosphorylated p-casein 
after treatment with (A) pepsin, (B) trypsin and (C) combined proteolysis. Pepsin 
hydrolysis produced peptides within a retention time interval of 18-48 min, trypsin 
generated peptides within 5-58 min and an extensive number of peaks was observeù in 
the peptic/tryptic combined proteolysis occurring during 5-55 min; for this treatment a 
combined chromatographic profile included peaks obtained individually for pepsin and 
trypsin. In general, same peaks were detected in p-casein and dephosphory lated p-casein. 
A previous study (Grego et al., 1984) indicated that the retention times ofphosphorylated 
peptides, were less than those of the corresponding dephosphorylated peptides; a similar 
finding was observed for sorne peptides corresponding to dephosphorylated p-casein in 
our study. It is expected that a peptide containing less or no phosphoserine residues is 
more strongly bound to the stationary phase than a peptide containing phosphoserine 
residues. The RP-HPLC chromatogram for each enzyme treatment studied could not be used to 
identify the peptides produced; characterization of the peptides obtained for the native and 
dephosphorylated caseins was performed using LC-ESI-MS and MS/MS because oftheir 
ability to deal with complex peptide mixtures observed in the chromatograms obtained. 
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5.3.2 Identification of Peptides 
5.3.2.1 LC-ESI-MS of Native and Dephosphorylated a-casein and ~­
casein 
Figure 5.3 shows a representative LC-ESI-MS spectra for a-casem and 
dephosphorylated a-casein after combined proteolysis with pep sin and trypsin. The 
signaIs (mlz) 506.3 and 769.3 were identified only in Figure 5.3 (B) for dephosphorylated 
a-casein, indicating effects of dephosphorylation on a-casein proteolysis. From complete 
analysis of the LC-ESI-MS spectra a total of 25, 28 and 49 molecular species were 
identified for a-casein treatment with pep sin, trypsin and successive proteolysis 
(Appendix 3), respectively. For dephosphorylated a-casein 26, 25 and 52 peptides were 
identified (Appendix 3) only by molecular weights, after pepsin, trypsin and combined 
proteolysis. These signaIs were further analyzed by MSIMS (Section 5.3.2.2), in order to 
more fully identify all the peptides generated. 
Figure 5.4 shows a representative LC-ESI-MS spectra for ~-casein and 
dephosphorylated ~-casein after combined proteolysis with pepsin and trypsin. The 
signaIs (mlz) 497.2 and 553.8 were identified only in Figure 5.4 (B) for dephosphorylated 
~-casein, likely indicating effects of dephosphorylation on ~-casein proteolysis. For ~-
casein 44, 23 and 49 and for dephosphorylated ~-casein 48, 27 and 43 peptides were 
noted after pepsin, trypsin and combined proteolysis, respectively in both caseins 
(Appendix 4). These signaIs were further anaIyzed by MS/MS (Section 5.3.2.3), in order 
to clearly identify all the peptides generated. Our LC-ESI-MS results suggest that mass 
suppression did not occurred in the peptides derived from the caseins before and after 
dephosphorylation; thus contrary to the results obtained by Larsen et al. (2001), where 
85 
A 
Figure 5.3: (A) LC-ESI-MS spectra of a-casein and (D) LC-ESI-MS spectra of 
dephosphorylated a-casein hydroIyzed by pepsin-trypsin. SignaIs in bold 
type/circled indicate dephosphorylated peptides 
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Figure 5.4: (A) LC-ESI-MS spectra of p-casein and (B) LC-ESI-MS spectra of 
dephosphorylated p-casein hydrolyzed by pepsin-trypsin. Signais in bold 
type/circled indicate dephosphorylated peptides 
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the intensity signaIs retention time range for phosphorylated peptides were very low 
compared to other peptide signaIs in the spectrum, due to a combination of specific 
suppression of the signaIs for the phosphopeptides and metastable fragmentation of the 
phosphate groups. In the molecular weight range from 5 to 50 kDa analysis by LC-ESI-
MS exhibits better mass resolution than MALDI (Carr & Annan, 1996), which permitted 
the detection of molecular weight that varies slightly in mass. It was observed (Figure 
5.5) that the maximum number of charges for the peptides correlated reasonably well 
with the number of amino acids side chains (arginine, lysine and histidine) than can 
accept a proton at the low pH used in the analyte stream. In the case of peptides produced 
by the three proteases treatments, generally double charged species were present with a 
dominant [M+2H]2+ ion (Figure 5.5 A). Few smaller peptides with a single charged 
[M+Ht ion were identified (Figure 5.5 B). The evidence that these ions carried a single 
charge was obtained from the spacing of the isotope peaks, which were one mJz unit 
apart; doubly charged form of the parent ions was observed when the peaks from the 
isotope cluster of the daughter ions were spaced 0.5 mJz units apart (Yeboah et al., 1999). 
5.3.2.2 LC-ESI-MS/MS ProteinLynx and Mascot Search Engine for 
Identification of Peptides 
LC-ESI-MS/MS spectral data were analyzed using ProteinLynx and Mascüt 
search engine (Section 5.2.4.3). The results presented are the MS and the MS/MS spectra 
of selected peptides from the spectral analysis; the peptides sequences were identified as 
weIl as the specific parts of the parent molecule from which the peptides were originated. 
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5.3.2.2.1 Identification of Peptides from a,-casein and Dephosphorylated 
a,-casein 
Figure 5.6 (A) shows the LC-ESI-MS spectra used to generate the LC-ESI-
MS/MS spectra (Figure 5.6 B) of the triple charged peptide RlOO-L109 (m1z 423.9) from 
dep1wsphorylated a-casein after pepsin hydrolysis; from these spectra the identified 
peptide was RLKKYKVPQL (MW 1271.7 Da). AH identified peptides are listed in Table 
5.1 and the origin of these peptides is shown in Figure 5.7. Three similar peptides were 
obtained by the action of pepsin in a-casein and dephosphorylated a-case in, respectivel,. 
Native and dephosphorylated a-case in were c1eaved by pepsin at the same five peptide 
the dephosphorylated a-casein where the c1usters of phosphoserine residue were 
removed. Pepsin showed a preferential splitting at the L-X and F-X bonds for both native 
a-casein and dephosphorylated a-casein. It has been reported that pepsin c1eaves C-
terminal to aromatic amino acids and leucine (Athaudaa & Takahashia, 2002). 
Figure 5.8 (A) shows the LC-ESI-MS spectra used to generate the LC-ESI-
MS/MS spectra (Figure 5.8 B) of the triple charged peptide QS9-K79 (m1z 773.3) from 
dephosphorylated a-casein tryptic hydrolysis; the molecular weight indicates the loss of 5 
phosphate groups. Six and eight peptides were obtained by the action of trypsin in a-
casein and dephosphorylated a-casein, respectively (Table 5.1). The following ten 
peptide bonds were cleaved in both the native and the dephosphorylated a-casein: K7-Hg, 
sorne of these c1eavage bonds have been reported (Lemieux & Amiot, 1990; Lemieux & 
Amiot, 1989). Trypsin gave preferential c1eavage at the K-X and R-X bonds for both 
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Figure 5.6: (A) LC-ESI-MS spectra (m/z region 415 to 515), m/z 423.9 signal in bold 
type/circled and (B) LC-ESI-MSIMS spectra (m/z region 320 to 1000) of 
dephosphorylated a-casein peptic hydrolysis. Inset represents the fragmentation 
spectra of the peptide RLKKYKVPQL, experimental MW 1271.7 Da 
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Table 5.1: Peptides identified in enzyme hydrolysis products of (l- and dephosphorylated a-casein by LC-ESI-MS/MS 
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Table 5.1 (continued) 
Peptide: Pepsin 
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Table 5.1 (continued) 
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180-193 1 . 1 
\0 
tA 
Table 5.1 (continued) 
Peptide: 1 Contio.-----, Pep sin Trypsin il Pepsin-Trypsin 
Theoretical MW (Da), charge (Z) 1 ___ Exp MW_ (Da) 1 Exp MW (Da):E!pMW (Dl!) __ i __ Exp MW (Da) 
1 uamm:U:c:~:~::::~-CN, la-~:l ~~ 1 a-CN! ~~N 1 a-: !l~~ Il a-CNI ~egN 
IJ~ii~~~bQAME ...I~... ~LnLl __ t_ .. [~] 1538.6 
1 1640.8 3 1~1r---1 'Cir--I L~;~~;PFPEVFGKEK l~~~·7 J ___ .. _..1 _ L . !.__i . ______ .1_ _ .• r-l __ -",,-
'~*;~~~~DQAMED _.l_._I--~~Clu .. l .. _ .... _i[] 1653.7 
1759,3 !lieni! lB.C' 
HQGLPQEVLNENLLR 1 1 ..1.... i . 1 ,~~~~~~~_emieux & Amiot, 1990; 1989)1 __ ~_1_______ _ __ m_ ~_I~~.8~_L~~:9_J __ . _  Ir-'..;..::..::..;..::..::= 
i 1766.7,2 IiL~.illE!iLI (-IPhosphate) 1: I ! i 1 ~i~~ESTEDQAMEDIK J ___ .:__. _ -.. _. . l_.J _1766~7 1_ 1 
, 
1846.7,2 
DIGSESTEDQAMEDIK 
43-58 
1-
1846.6 i 
"N ~~ •• ~ 
\0 
0\ 
Table 5.1 (continued) 
-li 
Peptide: 
Theoretical MW (Da), charge (Z) 
amino acid sequence 
amino acid sequence in a-CN, 
Reference 
lPepsi" Trypsin' r 
Exp MW (])a) 1. Exp MW (Da) Exp MW (Da) 
Pepsin-Trypsin 
Exp MW (Dl!) 
." ." . .. . - .. 
a-CN .~ep . 
i a-CN 
_:. ' ..;;;.;.a-_c--,-N..;;...,l ~~NL a-cNl ~6i a-cN:1 ~~NI 
J!~I~:~~AEERJ1 ___ j~ __ J~~ ,'8[ ___ .' 
'~f.~;~ERYLGYLEQLLR 120789J! '" .l.iL "iCI, _il __ u 
' l 'Î ,1 ' . 
23152 '1 IO":QIC ···E·i 'C 
. !:~~~:~_~AYFYPELFR 1 ji_ 1. 2315,1!23~5 ,1._1..._, 
, ·1 ' 1 ., ., 2320,3 
1 .1 · • 
. __ .. ~.___._ J. l__L_L '" .1. __L ___.~_ (-5 Phosphate) QMEAESISSSEEIVPNSVEQK 59-79 2320 
, i~:1t~QKEPMIGVNQELAYFYP 132065 ,11111 :~II.. • 
125-151 1. . . J ..... .. t. . JI.. 1. .1 \ ..... 
~~~~L~AYPSGAWYYVPLGTQY 1 . 1 1 ~APSFSDlPNPIGSENSEKTTMPL 1 5444,5; 1 l, 
152-199' L .... 
Figure 5.7: Identified peptides by LC-ESI-MS/MS from a- and dephosphorylated a-casein 
after proteolysis 
ex.-casein Native Dephosphorylated ex.-casein Native Dephosphorylated 
RI 
-Il E 59 
H8 1 M 
Q 1 1 E G A + L 1 1 E 
P 1 1 S. 
1 Q 1 
E 14 1 1 S. 
1 -t- S. 
. 
V 
1 L 16 + 4- ~ 1 N 17 T E69 ..... ,.. E 18 1 E 70 
N 171 + 
L V 1 
L P 
1 ...L R22 N74 
- ...L - S. 1 F23 . 
F24 1 V 1 1 V25 - E 
A 1 Q 1 
p 1 K 79 
F 1 H80 p 1 
Q 1 Q 
V 1 K83 ...L ...L 
F 1 
E 84 1 1 
G 33 D 
K34 ...L V 
E 35 T 1 P K36 S 
V E 1 
N R90 
-+- ..... 
E Y91 
1 L 40 L 
S G 
K42 Y 
D43 1 L 
1 E 
G 1 Q 
S. 1 L 
E 1 L99 
S. R 100 
T 1 L 102 
E 50 + K 
D 1 K 104 Q y 
A 1 K 
M 1 V 
E 55 P 
D56 + Q 108 
L 109 
-1 · 
· K 58 E 110 · 
· 
· 
(Continued in page 98); see footnote at end of Figure 
97 
a-casein Native Dephosphorylated a-casein Native Dephosphorylated 
1 A 
V 1 
y 
p P 
N 1 s 
~ 1 G 
A 1 A E W 
E 1 y 
R 119 Y 
1/ V 
Q 125 P 
G L 
1 G 
H T 
A Q 
Q y 
Q T 
K D 
E 133 A 
p P 
M S 
G F 
V S 180 1 1 
N D 
-r- 1 
N 1 182 1 1 Q p 
E N 1 1 
L T p 1 1 A 1 
Y G 1 1 
F S 1 1 
y E 
P N 
E S 
L E 
F K 193 
R 151 T 
Q 152 T 
F M 
Y P 
Q L 
L W 
0 
s., Serine Phosphate, - • - Control, --- Pepsin, ..•••...... Trypsin and - - - - Pepsin-Trypsin 
98 
100 
%. 
415.2 
437.6 
.438.9 
417.4 
1'00 
11 
477.8 
17.548 
14.4Q7 
586.3 
1 
619.3 
500.6 
1 
1'633.4 
549.7 
",~.1.1 
~'i1.6 
11.96e 
~1 .. 104 
2'1.158: 
148.$ 
713. 
749.3 773.3 
831.2 
3.1.591 
23.48 
A 
875.$ 
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Figure 5.8: (A) LC-ESI-MS spectra (m/z region 420 to 900), m/z 773.3 signal in bold 
type/circled and (B) LC-ESI-MSIMS spectra (m/z region 300 to 1000) of 
dephosphorylated a-casein tryptic hydrolysis. Inset represents the fragmentation 
spectra of the peptide QMEAESISSSEEIVPNSVEQK, experimental MW 2320.3 
Da, indicating the loss of 5 phosphate groups 
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native casein and dephosphorylated a-casein. It is known that trypsin has affinity for 
peptide bonds which have arginine or lysine at the carbonyl si de of the peptide bond 
(Trevor, 1991). Dephosphorylated a-casein treatment with trypsin hydrolyzed the peptide 
bonds K79-HSO (Lemieux & Amiot, 1989), K103-YI04 and R1l9-L120; removal of the 
phosphate groups was determined from the rnlz 623.6 and rnlz 773.3 signaIs. Trypsin also 
hydrolyzed the peptides bonds ~2-D43 and Kss-Es9 where two phosphoseryl residues arp. 
present in a-casein. A difference in molecular weight of 80 Da for the same doubly 
charged peptide (D43-KS8, rnlz 923.4 vs. rnlz 883.4) in dephosphorylated a-casein was 
noted; confirming the loss of 1 phosphate group from dephosphorylation. Previous work 
(Adamson & Reynolds, 1997) reported the recovery of a peptide corresponding to asl-
casein (D43-K79) rather than the expected asl-casein (D43-KS8) and asl-casein (QS9-K79); 
this suggests that the cleavage site at KS8-QS9 of asl-casein was more resistant to tryptic 
hydrolysis than those at ~2-D43 and K79-H80. Dephosphorylation produced two peptides 
(D43-KS8 and QS9-K79; Table 5.1), indicating that the loss of phosphate made the KS8 more 
susceptible to trypsin cleavage. 
Figure 5.9 (A) shows the LC-ESI-MS spectra used to generate the LC-ESI-
MS/MS (Figure 5.9 B) spectra of dephosphorylated a-casein peptic-tryptic hydrolysis for 
the double charged peptide ~2-Ds6 (rnlz 826.9) which experimental molecular weight 
determined (1653.7 Da); the data indicate the loss of two phosphate groups when 
compared with the theoretical molecular weight expected (1814.6 Da). Combined 
pepsin/trypsin proteolysis of a-casein and dephosphorylated a-case in resulted in twelve 
and fifteen peptides, respectively (Table 5). Three different peptide cleavage sites were 
identified in a-casein F23-F24, L98-L99 and DI8I-1182 (Figure 5.7), in addition to LI09-EIIO 
100 
100 
18.734 
270,695 
32.9.19 
21~235 
12 .. 641 
! 
1 
1 
A 
KDIGSESlEDQAMED B 
200 400 600 S«I 1000 1200 14(11) 1600 
'16 ,0"161 
a ~J.y.&II!II:I..t.IfIIIJo!tt;l ~'l~ill.llLllj.JIIII~I.lYJ-U+-I~. '+-'-TI ~ll.l~~1 ~I ""1""'"T'"" ~.,...-,-;mjz 
a 400 600' 
tntz' 
/.soo 1.000 
Figure 5.9: (A) LC-ESI-MS spectra (m/z region 410 to 840), m/z 826.9 signal in bold 
type/circled and (B) LC-ESI-MS/MS spectra (m/z region 360 to 1040) of 
dephosphorylated a-casein combined (peptic-tryptic) hydrolysis. Inset represents 
the fragmentation spectra of the peptide KDIGSESTEDQAMED, experimental 
MW 1653.7 Da, indicating the loss of 2 phosphate groups 
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produced by pepsin and R2z-F23 and K34-E35 (Lemieux & Amiot, 1990) formed by trypsin, 
which wereestablished earlier. For dephosphorylated a-casein the following twelve 
peptide cleavage sites were observed after trypsin hydrolysis: Ew V 15, N 17-E1S, K34-E35, 
S41-K42, E50-D51, E55-D56, D56-157, S6s-E69, E69-E70, E7o-17!' N74-S75, E109-EI10, K79-HSO, 
sorne of these cleavage bonds have been reported (Lernieux & Arniot, 1989). Both native 
and dephosphorylated a-casein showed in cornrnon ten cleavaged sites K7-HS, EWNI9, 
F24-V25, QS2-KS3, KS3-ES4, R90-Y91, R119-L120, F179-S1S0 and K193-TI94, sorne of these 
cleavage bonds have been reported (Lemieux & Amiot, 1990; Lemieux & Amiot, 1989). 
In addition to the known preferred cleavage sites for pep sin and trypsin enzymes 
(Athaudaa & Takahashia, 2002; Trevor, 1991); our results suggest that E-X, D-X, S-X 
and N-X are also cleavage sites (Figure 5.7). 
The higher number of peptide cleavaged bonds determined in both the native and 
dephosphorylated a-casein for the successive proteolysis rnay be due to the ability of 
pepsin to facilitate the tryptic proteolysis of case in (Ono et al., 1998). The presence of 
neighboring peptide bonds cleaved (Figure 5.7) indicates that degradation of sorne 
peptides occurred; for example dephosphorylated a-casein peptides Hs-EI4 and Hs-LI6 
(m/z 403.7 and m/z 509.7) are likely from degradation of Hs-N1ï (m/z 566.8). 
Identification of the peptides hl-K79 (m/z 506.3) and presumably the degradation 
peptides ~2-E50 (m/z 482.2), ~2-E55 (m/z 769.4) and E69-K79 (m/z 635.4) were only 
observed in dephosphorylated a-casein subjected to combined pepsinltrypsin proteolysis 
after the removal of one or two phosphate groups, respectively (Figure 5.7). 
Dephosphorylation favored the action of the proteases since the presence of phosphate 
may cause a steric effect on the enzymes by blocking the access to a close cleavage site 
102 
where a phosphoserine residue is present (Ono et al., 1998); caseins are known to have a 
strong negative charge at the phosphoryl groups on the surface; it may be difficult for the 
protease enzymes to reach the c1eavage sites of the caseins in the proximity of the 
negative charge. 
5.3.2.2.2 Identification of Peptides from ~-casein and Dephosphorylated 
~-casein 
Figure 5.10 (A) shows the LC-ESI-MS spectra used to generate the LC-ESI-
MS/MS spectra (Figure 10 B) of the peptide S17-L45 (mlz 859.8) obtained after c1eavage 
of the bond Lw S17 in dephosphorylated p-casein; the molecular mass of this peptide 
(3439.5 Da) indicates the efficient removal of 4 phosphate groups. AlI identified peptides 
are listed in Table 5.2 and the origin of these peptides is shown in Figure 5.11. 
Four and five peptides were obtained for P- and dephosphorylated p-casein after 
peptic hydrolysis, respectively. P- and dephosphorylated p-casein were c1eaved by pepsin 
and F205-P2o6 (Table 5.2); sorne of these findings have been confirmed previously 
(Guillou et al., 1991; Lemieux & Amiot, 1990). Pepsin showed a favored splitting at the 
L-X and F-X bonds for both P- and dephosphorylated p-casein (Athaudaa & Takahashia, 
2002). AdditionalIy, pepsin c1eaved a quadruple charged large peptide once 
dephosphorylation occurred (Figure 5.11). 
Figure 5.12 (A) shows the LC-ESI-MS spectra used to generate the LC-ESI-
MS/MS LC-ESI-MS spectra (Figure 5.12 B) of the peptide E2-R25 (mlz 881.7) obtained 
after tryptic hydrolysis of dephosphorylated p-casein, indicating the loss of 4 phosphate 
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% 
100 
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40;592 
16~3e2 1,5.85,4 
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132 ,3 
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72$.4 
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,7384 
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Figure 5.10: (A) LC-ESI-MS spectra (m/z region 480 to 900), mlz 859.8 signal in 
bold type/circled and (B) LC-ESI-MSIMS spectra (m/z region 320 to 1040) of 
dephosphorylated ~-casein peptic hydrolysis. Inset represents the fragmentation 
spectra of the peptide SSSEESITRINKKIEKFQSEKQQQTEDEL, experimental 
MW 3439.5 Da, indicating the loss of 4 phosphate groups 
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Table 5.2: Peptides identified in enzyme hydrolysis products ofp-casein by LC-ESI-MSIMS 
theoreticai~d~a), charge .. ~!~;;:~~) .. ,[ .JI!pp~nQ>~) .. [ ...... ~!:~@~t.. ..... ~xp.~ Q>~1 . .c 
~~:o::~:~:~1:C:c<:NLJ~!1 ~-CNI ~0N J~-: L~JN_il:NI ~~~J 
, 741.4,1 i Ir' ·c:n:r--·r---GPFPIIV . ! '1 • ill : 
203-~09, (Vlss~r et al., 1995; 1 i.il 741.3 
Lemleux & Amlot, 1989, 1990; ! ; ! 
Miralles et al., 2003) i i i 
-_ .. , ... " ,... ., ...... .... r' ---
1 747.3, 1 ~r--' 
YQEPVL 1 il i 
193-198, (Lemieux & Amiot, :. 
;1., .... _.,' ,\ ;1 ,'-1--
747.4 
1989, 1990; Schmelzer et al., 
2004) 
................. ... ... .r--'......=..;......=..;. .....--"===, ,.......-.-----
829.4,2 
AVPYPQR 
----
177-183,(Visseretal., 1995; l 829.4 829.4 829.4 
Lemieux & Amiot, 1989, 1990; i . 
... çar.1es& Ribadeau ~~~~s, 19~6) ...... ~ ..... J...... .".. . ..... ,.. .. ., .. ,.... .. .. ,. 
EipiHN L __ lIJ--[].JS77A[877.4J 
940.4,2 '1 lr--~ r---' ~~~AQTQ 940.5 .. 11 .1..: 1 .. .. ...1 .1940.4 1 940.4 
..... 
C> 
0\ 
Table 5.2 (continued) 
theoreticar~d~a), chàrge 1 1f!~:;o~~L,[. ~x~p~~Œ~)r-~x:~i(na)w l~!jlMW@~Ln~ 
. ~Z) 1 ~-CN '1 Dep. '[ ~-CN il Dep.[ ~-CN '~I ~-CN I~ a~i:~;;i;;;~~~:~:~:~;:ÇN .'. . ...... ! .~-~~.I .w .................... il~-~~.. .... ... ..;l..~-~N .. ; ................. _Jtw.~~.=~ ...... ~ 
QEPVLGPVR.. : 1 l i i 993.6 ! : 993.5,2 . [j![J:DlCC-'n"BI[j'
.~;2~Ol~~~t:~~:~~.~~mlOt,.. . . ...J ......J .... _ .. J ........... .......................... 1 ... J ....... ~J 
9943 2 ~"D'D!LIJC'niB: • , 1 ; t \ i SSSEESITR i 1 1 . ; 1 ; 994.3 : l-i_;~osphates) U· ". :c··-n········'c······· ............•~Ir--............iD····· ·· lB····· ..... : 1027.3,2 : : , ': i:
~~~ AQTQS .. . . .L.l. ..J_. ...........: .'. • ......~ J.1.~2.~.~3 .. : 
1028.6,2 ~Illlr--njnn:~ .~~JoLPLL 1 1028.6l.jll .. ..J ............... i .... ..jt~028:5: 
J%~~!!~).n_ u. IL_ .. J._ .. ILnl.l.L~7~5 .~ 
, 1129.6,2 F'i-:C' ~'n:~---:E LHLPLPLLQS 1129.7 '... '. '1 .!, 1129, .7, ,'. 
133-142 . ' ': i 
, .. , ....... ,. .... 1 . ' .. .. ... . ... . 
....... 
o 
..... J 
Table 5.2 (continued) 
Peptide: 
theoretical MW (l>a), charge t.~!~C~O~a) [:F;!:~n(l>.~) .~ ..• [n:F;!P..l\fW(I>~) .1 E!p MW (I>~) 
. . [ ~-CN~[ ~-CNI Dep. 1 ~-CN I~I ~-CN .~ ami:Om~~; ~::u::~:e:U~;_ç~. . ....1 '.. f3-CN ;.. .......... . J f3-CN
m
..! L~-=N ... ' .... .....Jf3~~N 1 
(Z) 
1139.52 0 1['[1 ·c·c:r='pi , ; : ; 1 :; VYPFPGPIHN :;.i . . · , : î~:~i (Lemieux & AmiOt,~ ~ ... . L . .. .1 .. ~_L ,1139.6 i 1139.5 
1140.4,2 i~r--r--I .Ci~~~ ~~isAQTQSL ... ... m •• I~~~~·5 il ....... 1.. ...J...) ......1.....:1.1140.5 !L 114~~1 
1150.6,2 !~IiC-1 'Ii~r--II ?~~~~PFPIIV .il .. ~1~O.7H ..... ......:l115~.5:lll~~.61.. ...!I.. il .....:1.. ...1 
YQEPVLGPVR l, j :1 . j . 1 ; 1156.5,2 IB:C'[JH [jlCiR'E'~~~~~02, (Le~i~~~~ A~iot, ........ J.~~.5~~.6 !. ..... .... . ............. ln~ ... ~m~ .~ .... _._ ~ ...... ~ ...... . 1156.5 ; .. 1~.~6.5 .. i 
SLSSSEESITR i i • 1 i" 1196.3 . 1196.3 :n ['[1 . Ci C' [iF·~-;_~;osPhates)d..., '.. .J ... m. i.. . ... .1 
~~~F~GPIHN ,.,.11 ....... ;tl 'r--. ..1 r--..... ~ ... ' ..... 11252.5 'F.25.2 .. 6. i. 
58-68 .1.. ..... . .. ' . 1 LI.. . ......... l.... . .... ... . .' 
...... 
o 
00 
Table 5.2 (continued) 
~---.--_._- ·l Peptide: Control' Pepsin theoretical MW (Da), charge ~!p MW_(Dat;_~!p MW (D1:i) _ F:!pMW (D~t_JL._:E:!p.MW (Da) 
. C!') 1 ~·CN '1 Dep. '[ ~.CN Dep. 1 ~.CNI Dep. 'I ~·CN I~ ~~!;::~~~~~du~~~~~:C~_CN .__:_~.~=~j __ ..: ~-CN ..............;I~~=~L.. Il ~-CN; 
1256.7,2 r~lir--- ·r--D'lir-:::-_.~~~~PLPLLI~256·.~!L __ .JI_ ..... J . .............:.... ... .'L__ .. ll~56.7; 
1 1269.6,2 cl d, 
L YQEPVLGPVR 
192-202, (Lemieux & Amiot, 
):2.~22}.2.90) . 
f~~iwSQS '11283.6J L 1 1 Jl~ , 
'~fp~PNSLL:l_~J1299.6 .• 1299.7 ni. _.r. _ in 
'
1307
.
6
,2 n'lir--- r--Dl~C-:-~t~~NIPPLTQT .. ...;\1. ........... • 1 ...; . ...lL.111307.7: 
1319.6,2 ilr--r--- r--I I~r-==-:~PPFLQPEV 1 .ll ..... J .. ... ......... 1 . ...... :111. .....J 1319.6 : 
1339.6,2 r-~r--- r--! !~F ~~~PGPIHNSL 1 . .. .. '1 ______ 1. ... .. l.. ......1 t__ ... ~. 1339.7 . 
.... 
o 
"D 
Table 5.2 (continued) 
Peptide: Control Pep sin f"-"-" l theoretical MW (Da), charge Exp MW (Da) . ! E~p,,~.(D!l) .....•....... Exp MW (Da) .\ E_xp MW(D~l ... 
. \Zl! ~-CN i~1 ~-CN :~! ~-CN~! ~-CN~ ~mi:o,m~~;:::l!~:~;~~c~_C!!.JP~C~ 1: I.~-~~. .... ......." P-~N .'. . .............. ~_~~C~._; 
1360.6,2~li~r--r--1 .~~ ~~~TEDELQDKI. . .lj.......t __ .H..,l,il :I,_JI~~6~.~.J 
1367.5,2 n'~Dir-r-~D!1.:l ~!!!~~~:~D . .. j !J __ J. J, . _ ,_il~3,6~5.J 
1371.7,2 ·C":ln.~r--~n:~r-:::::l ~2~~~~HLPLPLL J 1371.7 '.' . il ........... ,,, ....1... ..• . . .. 1 .................il13~1~8 ,1 
K~~~~~LPP~ _~l .' t J,_i~1 Il 1380.7ill~80~61 
LLYQEPVLGPVR i.:· 1 i • 1 1382.6,2 ~'CiD'C:CI · pl8'ii~~~~I(i::~~:~i~a:h~9951. ' . i_ .' ... ' ........ " ..... 1 ' 1382.6 1:2~~ .i 
1395.6,2 ~r--r--Ir--I ~I • ,y&~~~FTESQSL .. , .. ~.. ...1 . 1 ... . l " ...1_... 1.. 1 .J 13~5 ... ~ t1395~ 7] 
1432.8,2 r-~:~'~I' ~F' IQAFLLYQEPVL . 1 • .1' 1. 1432 ... 8. '1 
187-198 .! { " 
...... 
..... 
o 
Table 5.2 (continued) 
Peptide: 
theoretical MW (1)a), charge 
(Z) 
amino acid sequence 
amino aci~ sequence in a.-CN 
,lControl" ·i-Pepsi;---- . r 
'L_l!:~p~JPa) 1 Exp l\1W(n~J L.l!:!p ~(1)aL L E!p MW (1)~). 
'l p-CN I~ep. [P-CNI Dep. [P'{;N .. [Dep. '.[ p-CN •. ~ep. 
, i I3-CN i I3-CN : I3-CN . 'I3-CN , 
, ...... ..••. .•..........•... ', .•.•... ; •...........••••. c ................. ,. . ......... . ........ : 
i : ." i, : , , . '! '
'cr-n' r-~r-~ 
. . .. L_~!I ... ...• . .. JI .... J ....... '11 1446~ : 1446.7,2 PVEPFTESQSLTL 115-127 
, 1450.7, 2 'I~-r-jl r-c:C-:iC-:: ;~~~~~:1~~~~!.,2Q~~).j. 14~~·~JL.~ .. , ..... ..J ........ L ........... j ........ ~_ .. _ .... !t 1450·~_L.l~.~~~~_; 
1452.7,2 !D:r-r-I r-~F·.r--1~~FPGPlllN~L. '~t .... . ..... 1. J ... L .... .11452.71 ..... " 
1 nr-~I 'oo·ne· 1457.6,2 . i l .. J ", 1 : · i Y~~iO~PVRGPF '. ... .. .: ... 1 1457.7 111457.8' ... j... ..... 1. 1 i 
PVLGPVRGPFPIIV : : ! ., . 1 ; 1459.9; . 1459.9,2 i[j:c---·n:l Q:Cip··C·
19.6-209, (Schmelzer et al.,~0011 .... ...J_. . ..1. . .....J ... ~.. l_ .. '... . ... .: 
~~!Éi~VPGEIVE L __ iCnl L __ t __ inI1468.7 
~:~~PLPLLQS t . :C---~I c-Cr-1147L7 c 1472.7,2 r:=::--r-nl r-~~~ :~1~~~~:;~;;etal.,f004) Ll.4~2.61 '.:' 1 .... :1 ........ :[1472.8:1 1472.7 • 
...... 
...... 
...... 
Table 5.2 (continued) 
Peptide: : Control i Pepsin Trypsin; Pepsin-Trypsin ~---~-[ -theoretical MW (Da), charge 1 Exp MW (D~l _1._ }:xp.MW (Da) . EXJ?MW _(D~)l~!p_MWJD~) . 
. ~Z)I ~-CN I~il ~-CNI Dep. 1 ~-CN~I ~-CN •• ~ alll!;;;~:~:~l!;~~:~:c~-CN ;._ _Lf3~=~J ._' J f3-CN .. _; L f3-=~_ !.. ...IIf3~=~ .. ; 
1 ~~~T~DE~~D~. :01._11.' I~_ Il. .JŒ~t489.7 
:~:L~~~~ J-~-J_.~l .. _I~ .. I_._L._ .J.l~7.8J .. u· 
, 1510.7,2 'r--:O!r--I ~I:~E .~3;~~~~~~TVM 1_ _ ~ .. ! .. _ ._JL ..... __ JI 1_ .... _1 __ . ___ ._jLl~~~.~J __ ~.5_1_~·~i 
1511.7,2 ~nic.-:-I r--' il if :~~FAQTQSL 11511.6ijLI511.7 il l.. . ..... !.. ..... L. ... __ .... L .... 
IVESLSSSEESITR . : l' · i 1 15357 '1535.7,2 n!n1c·~n.n;~-F\~r;Osphates) . . ;. .. L .• . '. i ..... i .' • 
11564.7,2 r--'I:~I r--nr--~ I~~%PGPIHNSLPQ 1 ..1 ....... JL il 1 ................... Il'11564.7 
, 1585.8,2 r-:nr--t r--~r--F ~if-~NLHLPLPLL ,'._.iLI 1 ..' H _____ 15~5.9 
.... 
.... 
I:Y 
Table 5.2 (continued) 
r----Control -~r__Pepsin [ Trypsin '\ Pepsin-Trypsin 
theoretical MW (Da), charge! Ex:p MW (Da) [ ~J!:xp~~J!>~t_ .~~l!.l\1W (Da), .. ' ... J!:X:PMW (1.!a) .. 
am::~:i:~:~~~:~,CN{~·CN ,I~~NI:·~I ~~Ht·~IH~~N tP.CN:l~~~J 
1600.8,2 'r-=~~Ir--I .. r-:~ ::I~~HLPLPLLQ il1600~-". l\'_HJl l_I.'IH.J 1600·~c 
r!~TESQS~H ____ .[--L_J ._. il L __ . Cl.__l~609~7J 1624.7, 2 r~:::'J~~Ir-:Ir-:~ ~~EELNVPGEIVE .. ~_~~, L 1624.8. Il ...... :. ... ..... ...l .. _~~_~~.l.,!t il __11~624.~J 1677.8,2 r---~r-:ir-:~~n' ;~FPGPlllNSLPQ '\ ... ' .\. J .... J.. ...... :! . .1 1677.9'. . .. 1 
i ~~NiHLPLPLLQS IL:n!n'l'cnI1687.9 '11687.9 ' 
128-142, (Schmelzer et al., '. .......... .. '.' . ... . .... ·'1 ... ' ..................... '1 . ..' '.. . .. 1. . ................. '2004) '  • .. .!.. ..... '. '...: .........; 
169762 F'nn 'C'I 'P'E' • , ; ; . : : t j i WMHQPHQPLPPTVM: •. '! l' • ~~~~~56,(SChmelzer,~~~~_ . ",,1697.6 , , ...•. , .. ,.. , ,.~ .. "._ ,',.~ __ ~ 1697.6 ,,097.6, .. 
1800.lJ,2 
LTDVENLHLPLPLLQS 
127-142 ~ji~ 1 ~R~ 
-
-w 
Table 5.2 (continued) 
Peptide: Control' Pepsin Trypsin [ --~~[ theoretical MW (Da), charge .Ji:~p~~(!>a) ...... Exp ~~(Da) E:x:p~~Q?~a) ._l 
. ~Z) [ p-CN i~[ p-cNI Dep. 1 P-CN~I P-CN .~ 
ami::':: :~:u~~~::C~_CN '. .. _ ... .11 P-_CN _ ,lp:CN . . .. J!:C~ i ____ J P-CN._, 
1833.7,2 l--I~nl 'D:r-:~E t~:~~~;;;~ELQDK.J_ .. LJI_ .J. .. . . .. _ Jl... ~J ... ... ; 18337 
1879.92 i[JiC!CI 'C~D'RL ' '~l :' YQEPVLGPVRGPFPIIV ' '; . 1 . : ' l l l ,' 1880 l , ~~~~9, (Schmelzer et al., ... 1 ,J . ... i '. LI. . . .' 
i 1902 2 :Oir---Cll r--Dir---r-=:-~~~~~HLPLPLLQS'EU'-~~n~mcl""'D' ··J~8 
.. ~~!~QPHQPLPP~~ ....... : .1.~~2·~~Jl.~ ..... ~._.'I. ~ ....... ~.~:l~~_.. .... ,~",~~.~ ......... ~~ .. ~jl.~912~7 il. 1~1~~~.: 
1 [J'n'nl F'E.nF· 1980.8,2 .! Il .'. (-1 Phosphate) '.·:I I!·. FQSEEQQQTEDELQDK 1·1 1980.7. 1980.9 . . 1980.8 . 
33-48,.<Miralles et al., 2003) . . __ . __ . ; . ... '1 . . : __ ...... ' i .. . 
21452 [J'nn'! 1-~nnF 
LNvPGEIVESLSSSEESITR . . ........ ~ . . 1 ... . . '.. ..... 2145.2 . ( -4 Phosphates) . '1 · 
6-25 . ..... .. ;. 1..... .... .. 
.... 
..... 
~ 
Table 5.2 (continued) 
Peptide: r Control tl Pepsin -~I Trypsin 1 Pepsin-Trypsin 
theoretical MW (Da), charge (Z) 1 ~xpMW (D~.)J . __ ~!P M'Y(Dall Ex]> M'Y (D~) ....... Exp~_@a) 
ami:Om:~: ~:~d~;:~:~:c~_CN ~-CN l.~~~.i[.~-~~:l_f-~N ~l ~~C~.· [ .. ~~~ __ : 1_ ~-C~ __ ~  
2185.1,3 H '[J'D·C.~E:D;' DMPIQAFLLYQEPVLGPVR 1 • 1 1 :1 ,..,,"" ; : i 
184-202, (Visser et al., 1995; '1 ; l : 1 2185 2185.1. ! 
Miralles et al., 2003) 1; i • ; · • i 
.. _ .......... w .• __ .w_.~ ....... ___ .~._w· WH __ " ._.. .. • '.w. .. ... . W ._.w .. _ ... ~_c ... __ .... ____ ... ,. ____ ... __ •••. ,1 .. _ .._____ . _. __ w .••• _w .~ ... w ___ .,_._.,. ___ •• _._ ,~ __ . ___ . __ ...... __ 
, 1 'O'CC'r--CEC 2280.1, 3 l, i i il. . ' , L.~i~r~~~.~~~~~~SVL.J_ ..... _l ___ ._. __ i .. ___ ~.J.__w_; .... ____ : .. _ .. _.. __ !_.~280.1_j .. ____ .. ,,_.: 
12429.1,2 il :[J,r--r--I r--I:":JE ~~~:~~~~~~~~:) 1 •.. JL~~. iL. .1 1 _ .... 1242~.IJ24291 .. 
, ~JQ~HQPLPPTVMFPPQSVL 2466.1 Ijr--i'i ~112466.1 :12466.1 
143 161 J 1 t. __ .l.. . 1 . L .. "" ............ w •••••••••••••• ' L ... __ ................ . 
2542.2,21 'IiC!r--r--r--~E ;~~FP~~I~SLPQNIPPLTQT 1 t_.l_ ............ 11.. .... . 1 .......... 1 ..... ......1~~~2.2! ... ~~~2.2. 
'264523 '1 n'r-'r-~R'~L . , 'l' i' • (- 4 Phosphates) !. ! ..' î~~ELNVPGEIVESLSSSEESITR i ..:... ..... 1 2645.3 il... '. ......... . . 
1--' 
-VI 
Table 5.2 (continued) 
r Control--~ [pepsin ! 1 
t .... 1!:!pMW {l>at .... Ex..p~m~LJ ... ~.!p MW (Da) ... ·1 ..Exp MW. (D~L .. 
Peptide: 
theoretical MW (Da), charge (Z) 
amino acid sequence 
amino acid sequence in a.-CN il .. ~-CN I .. ;~~J~-~~ t~~~nIL~-.. ~N 1 ~~N_:FI .. ~ç~~ .. , 
r-~-r;-~Q-l:-':-VL-P-VP-Q-KA-VP-YP-QRD-M-r[28M,5 [ ..f~l_ jC~12805.51 ._. 
2876.5,4 · ••. F.C .... l]i ..... O: .. LC .. L876.6 '~'. SLSQSKVLPVPQKA VPYPQRDM ! 1 • • l! 1.,,i~f~~?.... .i.. . .•.............. ' .............. i ............ ~! ............... ........... . .' ......... ;\ .............. ) 
: ~!~KF~S~E~~~~~_L t .... 1 ..... t._J __ . CI.292:1. __ : 
i 3439.5,4 3439.7 l ni' 
(-4 Phosphate) ; ! '1 1 : ~~E:ITRlNKKIEKFQSEKQQQ i ! i il
~~i~~Q~QSLVYPFPGP::PQ 'r-n":nr-r35S:7!5355.9 ','" ......• r-1 =.=.=, ... = .... = ...."' NIPPLTQTPVVVPPFLQPEVMGV 1 ;'. i. '. 1 
SK :·1:· ·1 
49-97, (Visser et al., 1995;1 
Miralles et al., 2003) '! 
'1 
Figure 5.11: Identified peptides by LC-ESI-MS-MS from ~- and dephosphorylated ~-casein after 
proteolysis 
p-casein Native Dephosphorylated J3-casein Native Dephosphorylated 
RI ...L Q 1 1 
E2 1 T 1 1 
L 1 Q56 1 1 
-+ E S 57 -. 
-E -1- L 58 + ...L. L6 1 V59 ...L 
N Y .,-
V 1 P 61 
-+ 1 P 1 F 1 1 G 1 P 1 
E G 1 
1 12 ,- P 1 1 
V 1 1 1 
E 14 - P 1 1 
-
1 S 15 
-
N68 1 
L16 -1- S 69 1 -1-S 17 ,- L 70 
...L ~ P .,-
-L. ~ Q72 
-1-
E N 1 
E 1 
S 22 P 
1 P 
T L 
R25 T 
1 Q79 
N Y 
K P 81 1 
K V 1 1 V 
E V 1 
K P 1 
F 33 ...L P 
Q34 1 F 1 
~ 1 1 L E Q 
E 37 T -1- P 
Q 38 1 1 E 1 ...L. Q 1 1 
V92 1 1 
Q M93 
T 1 1 G ;-
E 1 V 1 D43 S 1 
E ,- K97 
L45 1 V Q46 1 K D E 
K48 -1-
- + A 1 49 . ~ 
..L - M H - · A 
· 
· 1 P · P 
· F · 1 K 
· 
· A · H 
· · 
(Continued in page 117); see footnote at end of Figure 
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[3-casein Native Dephosphorylated J>-casein Native Dephosphorylated 
K p 1 
E Q 1 M S 161 
P V - -1-. 
F L 
P S 
K L 
Y 114 1 S 
P 115 1 -r- Q 
V 1 1 S E K p 1 1 V 
F 1 1 L T 
1 P E 1 V 
S 1 1 P Q 
-'- -'-
Q 
S 124 K 
L 125 .L .L A 177 
T 126 1 1 V 
L 127 
.L .L P 
T 128 
........ 1 -r- y D 129 P 
V 130 . 1 -1- Q 
E - ..... 1 
-'-
R 183 
N 132 
........ 
.L D 184 L 133 T M H 1 P 
L 1 1187 P Q 
L 1 A p 1 1 F 1 
L 1 1 L 191 ~ L 140 
-1- - - L 192 .L T Q 141 ....L. 1 y 193 ....... 
-S 142 :::c 
-'- + Q 194 -W 143 E 1 :::c -M 144 T P 196 1 
H 145 -r- - 1 
-1- V 1 Q 1 L 198 1 T P 1 ........ 1 G 199 T -H 1 P 1 Q 1 V . 1 P 1 1 R202 ..L L 1 -- -,-G203 p 1 p 
P 
-'- F205 T 154 
-=- 1 P V 1 
M 156 . 1 1 
- -F 1 1 V209 
P 
~, Serine Phosphate, - • - Control, -- Pepsin, ••••••••••• Trypsin and - - - - Pepsin-Trypsin 
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100 
008::3 
~70.2; seo;3 
445.1 
619,.3 
19.8 
600. 
10.529 
100 
9.954 
23.775 
11.309 
20294 
11.309 
o 500 
l 
1 
780,4 
7A4A
1
1 83Q:.4 
9.45 
31,4 
1)1.4 
23.775 
4.519 28.984 
24.519 
20.8 27.973 
1000 
mlz 
A 
1324.2 
1323.7 324.1 
, 13:18.9 
.' 
ElEElNVPGEIVESlSSSEESITR B 
27.733 
28.717 
43.561 
1000 2000 
27.733 
28.478 28.984 
1500 
Figure 5.12: (A) LC-ESI-MS spectra (m/z region 400 to 1350), m/z 881.7 signal in 
bold type/circled and (B) LC-ESI-MS/MS spectra (m/z region 400 to 1600) of 
dephosphorylated ~-casein tryptic hydrolysis. Inset represents the fragmentation 
spectra of the peptide ELEELNVPGEIVESLSSSEESITR, experimental MW 2645.2 
Da, indicating the loss of 4 phosphate groups 
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groups. Trypsin cleaved the same six peptide bonds for p- and dephosphorylated p-casein 
K32-F33, ~8-149, K9rV98, K l76-Am, RI83-DI84 and R202-G203 (Table 5.2); sorne of these 
cleavage bonds have been reported (Miralles et al., 2003; Visser et al., 1995; Cades & 
Ribadeau Dumas, 1986); only the cleaved bonds RI-E2 and R2S-h6 were found in 
dephosphorylated p-casein. The peptide F33-~8 also reported previously (Miralles et al., 
2003) occurred in both the native and dephosphorylated p-caseins; it was determined 
from its signal (m/z 990.4) that one phosphate group was lost before the action of acid 
phosphatase, this phosphate like1y was lost during the incubation conditions required for 
dephosphorylation. The preferred cleaved sites R-X and K-X for trypsin (Trevor, 1991) 
were also confirmed. p-casein has been reported (Swaisgood, 1992) as a flexible 
molecule in the region of the N-terminal domain, resulting in susceptibility of the lysine 
residues to proteolysis by trypsin. Hynek et al. (2002) demonstrated with a mode1 
phosphopeptide of p-casein that tryptic hydrolysis of the peptide bond K-S was easily 
cleaved when phosphate was removed, making evident that phosphorylation inhibit 
proteolytic breakdown, supporting the results obtained. 
Figure 5.13 shows the (A) LC-ESI-MS used to generate the LC-ESI-MS/MS 
spectra (Figure 5.13 B) of the peptide SWR2S (m/z 598.2) obtained from 
dephosphorylated p-casein after combined pepsin/trypsin hydrolysis, indicating the loss 
of 3 phosphate groups. Successive proteolysis (pepsin/trypsin) of p- and 
dephosphorylated p-casein resulted in thirty one and fort Y eight peptides, respectively 
(Table 5.2). Nine different peptide bonds were cleaved in p-casein as follows: E21 -S22, 
L4S-Q46, QS6-SS7, KS8-Is9, G97-V98, L153-SIS4, YI93-QI94, E1 9S-P196, G199-F200, in addition to 
Q198-G199 produced by pepsin hydrolysis (Figure 5.11); sorne of these cleavage bonds 
119 
100 
23.734 
'12.613 
1.74 
12.24 
8.481 
o 600 
782.4 
744.8 
43.836 
42.803 
24.272 
30.983 
22.449 
28.403 
1000 
mt.z 
A 
B 
400 900 :1.200 
41.648 
140 .786 
42.803 
39.269 
40.612 
1600 
Figure 5.13: (A) LC-ESI-MS spectra (m/z region 400 to 1300), mlz 598.2 signal in 
bold type/circled and (B) LC-ESI-MSIMS spectra (m/z region 4400 to 1580) of 
dephosphorylated p-casein combined (peptic-tryptic) hydrolysis. Inset represents 
the fragmentation spectra of the peptide SLSSSEESITR, experimental MW 1196.3 
Da, indicating the loss of 3 phosphate groups 
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have been reported (Schmelzer et al., 2004; Visser et al., 1995; Lemieux & Amiot, 1989). 
For dephosphorylated ~-casein nineteen different peptide bonds were cleaved as follows: 
El3l-N 132, SWL16, N 132-L l33, E14-S15, D129-V 130, E37-Q38, P186-1187, Y 114-P115, Ew112, T128-
Ll29, L129-T130, F33-Q34' E5-L6, Q56-S57, V92-M93, D43-E44, Qn-N73, L145-Q146 and Q142-
S143; in addition to LwS17 and L198-G199 that were cleaved by pepsin and KJ76-Am, ~8-
149, K32-F33, RI-E2, R183-D184, R25-h6 cleaved by trypsin hydrolysis (Figure 5.11); sorne of 
these cleavage bonds have been reported (Schmelzer et al., 2004; Visser et al., 1995; 
Lemieux & Amiot, 1989). Additionally to the reported cleavage sites for both proteases 
(pepsin and trypsin); the cleavage ofN-X, M-X, T-X, E-X, Q-X, G-X, D-X, P-X, W-X, 
and V -x was noted; this supports sorne of the found cleaved sites determined for peptic 
hydrolysis of ~-casein (Schmelzer et al., 2004). Dephosphorylation of ~-casein treatment 
with both pepsin and trypsin enzymes also produced the signaIs: mlz 497.2 and 553.8, as 
degradation products of the peptide SWR25 with 3 phosphate groups removed. Four 
phosphate groups were eliminated from the peptide E2-R25 (mlz 881.7), degradation 
peptides L6-R25 (mlz 1072.5) and 112-R25 (mlz 767.9) and S17-L45 (mlz 859.9) were 
observed (Figure 11). Dephosphorylation of ~-casein enhanced the action of both 
proteases (pepsin and trypsin) where the presence of phosphate prevents cleavage. 
Moreover, the presence of a higher number of peptides found in p-casein and 
dephosphorylated ~-casein than those found in a-casein and dephosphorylated a-casein 
may be due to the high content of proline residues (35/209) in ~-casein and the non 
compact structure of this casein; resulting in ~-casein and dephosphorylated ~-casein 
more susceptible to be cleavage by proteases (Farrell et al., 2004). 
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5.3.3 Bioactive Peptides 
Several of the identified peptides from both native and dephosphorylated a-casein 
and ~-casein can be considered as bioactive peptides precursors based on pub li shed 
information. Table 5.3 and 5.4 summarize the identified peptides containing a sequence 
with possible biological or physiological functions. Sequences peptides: YKVPQL, VAP, 
FVAPFPEVFGK, LAYFYP, DAYPSGAWY, TTMPLW, YPFPG, IPP, VPP and LLY 
have been reported to have antithrombotic or antihypertensive activity (Meisel & 
FitzGerald, 2000; Philanto-Leppala et al., 1998; Maeno et al., 1996; Maruyama et al., 
1987); RYLGYLE and YPFPGPI have been reported to have opio id activity (Meisel & 
FitzGerald, 2000); LL Y has been reported to have immunomodulating (Migliore-Samour 
et al., 1989) and KIEKFQSEEQQQ has been reported to have mineraI utilization 
properties (Chabance et al., 1998). 
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Table 5.3: Bioactive peptides precursors found in a.-casein hydrolysis products 
" ~ , , ,., ~, "., <"" " , c,'(' 
" 
c Il '''------'-,-'--'---------'-- -",-,---------,--,-- _m_m ____ ''''_''', _______ " ______ ,, ,_m".,_" ____ ,m_m __ ,, --"" ............ 
Peptide:. ' ' 
MW (Da), Z 
>~ 
amino acid sequence 
; 
Bioactivity Origin Reference ,~~ 
~; amino acid sequence in a- i , , 
eN , ~ 
, """,,,,,,, 
j 
,,',,''',' "'" mm ' "~'cc"~ ,,' " cc" 
1
127
1.7'3 ! Angiotensin-l- a-CN pepsin, Maeno et al., , ~~~~~VPQL 1 converting enzyme Dep a-CN 1996 , 1 (ACE) inhibitory ip~psin 
,,,,"cc,, 
, 
"~,'CC"~,'"','" 
" 
'r 1384.9,3 Angiotensin-l- a-CN pepsin- Maeno et al., 
,LRLKKYKVPQL converting enzyme trypsin 1996 
99-109 (ACE) inhibitory 
", "'" , " """"" "~'CC, , ,,,, '"'' ' rPa-CN -~871,3 ' ~ngiotenSin_l- r Maeno et al., (-1 Phosphate) ~ converting enzyme : trypsm , 1996 YKVPQLEIVPNSAEER (ACE) inhibitory 
104-119 
': 1089.6,2 Angiotensin-I- a-CN pepsin- Maruyamaet 
" 
VAPFPEVFGK i converting enzyme trypsin, al., 1987 
~ 25-34 '; (ACE) inhibitory Dep a-CN , peps in-tryp~in 
" r 1236.6, 2 r~ngiotensin-l. 
, 
a-CN pepsin- taruyamaet 
FV APFPEVFGK Iconverting enzyme trypsin ' al., 1987 , 
24-34 i (ACE) inhibitory , , 
. . ...... , """",,, 
"', 
", 
1383.7,2 i Angiotensin-l- i a-CN & Dep a- Maruyamaet ~ FFV APFPEVFGK converting enzyme , CN control, a- al., 1987 23-34 (ACE) inhibitory CN & Depa-CN , 
1 
trypsin, a-CN , 
~ pepsin-trypsin 
T : 1 a -CN control r--'--------1640.8,3 r Angiotensin-l- ' Maruyama et " ~~~~PFPEVFGKEK : converting enzyme al., 1987 , (ACE) inhibitory 
"" 
---
" 1846.7,2 , Mineral binding L~NttyPSin Schlimme & \ DIGSESTED(lAMEDIK , Meisel, 1995 
43-58 
'"~,m, , " " CC" """" ",w,,,,,, ",cm,,,, , " m,o, N.=.' .. ~m".'Nm' 'WC"~ 
" 2079,2 J :IOld t-CNeon:ol , Maruyamaet " EDVPSERYLGYLEQLLR al., 1985 ! 84-100 " --_::'_-, 
- r 2315,2 : Angiotensin-l- <x-eN Trypsin, i Philanto-! ~r~~~VNQELA ~~YP~LFR l , ~1~~~~;~i;~~:e i Depa-CN Leppala et al., 
li trypS,!l1. "", 1998 ,"'. 5444.4,4 Angiotensin-l- a-CN control Philanto-'~' QFYQLDAYPSGAVVYYV ~ converting enzyme , Leppala et al., , 
,( PLGTQYTDAPSFSDIPNP (ACE) inhibitory , 1998 
,': IGSENSEKTTMPL W Immunomodulatory 
r: 152-199 
Underlined sequences reported as bioactive peptides 123 
Table 5.4: Bioactive peptides precursors found in ~-casein hydrolysis products 
".'-,-"'.,-, ... ".,_._------,'" ---------- -,-----_.'-, --" .. __ .""'._--"',, .. ,'" 
Peptide: 
MW (Da),Z 
amino acid sequence 
amino acid sequence in 13-
eN 
1139.5,2 
VYPFPGPIHN 
59-68 
. 1 
Bioactivity Origin 
Angiotensin-l- ' trypsin, Dep 13-
Reference 
Meisel & 
FitzGeald, 
2000 
, 
Opio id .'I3-CN pepsin-
. 
con. v. ert ..~n ...g. e?zyme • CN. pepsi.n-
• (ACE) mhlbltory : trypsin . 
~":"""'12-5-2-.5"":',-2------'---C--":"""""': Opioid ~'';''-C'-'-N-p''':'''ep''':'''S-in-_--~eisel & 
L VYPFPGPIHN Angiotensin-l-' trypsin, Dep 13- ; •... F.i.t. zGeald, 
58-68 converting enzyme i CN pep sin- • 2000 
,-C-----.:....:---.:....:---.:....:---.:....:'=m'ç~~~)illlübitory .. , .. 1. trypsit:t .... . ' 
Meisel & 
FitzGeald, 
2000 
""'ï-29-9.-6,-2- If Opio id i[ I3-CN pepsin, 
~~:PGPIPNSL i . f1~i~~~~~;e i :;!CN 
"rÏ299.6'2 ,:.:....:--C---C---C--=......,·rlmmunomOdulatory :.1 fl-CN pepS'-'-in'-'-'-c--=.r Migliore-
VYPFPGPIPNSL ; Dep I3-CN . Samour et 
.. 59-70 . pepsin . al 1989 
, ,,', "." A' "'~, 
.': [ Angiotensin-l- ~rfl-CN pepsin, 1299.6,2 FitzGerald :. VYPFPGPIPNSL convertmg enzyme 'Dep I3-CN & Meisel, 
59-70 (ACE) inhibitory ........ p~.p~in '" 2000 
, .... .. , ... '" ....... ...... "" 
" 
1307.6,2 Angiotensin-l- I3-CN pepsin- Philanto-
SLPQNIPPL TQT converting enzyme trypsin, Dep 13- Leppala et 
i; 69-79 (ACE) inhibitory CN pepsin-
, al., 1998; 
, 
i trypsin FitzGerald 
, & Meisel, 
1:: , : 2000 
i[ 1319.6,2 
1 
Angiotensin-l- ! Dep I3-CN ; Philanto-
~ PVVVPPFLQPEV converting enzyme 1 pepsin-trypsin . Leppala et j , 
't, 81-92 (ACE) inhibitory 1 al., 1998; 
i : , FitzGerald 
" 
& Meisel, 
; 2000 
,.i-. __ . 
-" 
,;, 1339.6,2 Opioid Dep I3-CN Chabance et 
VYPFPGPIHNSL Angiotensin-l- pepsin-trypsin al., 1998 
t 59-70 converting enzyme 
r (ACE) inhibitory , 
... 
,:\ -----1382.6,2 Immunomodulatory I3-CN pepsin- Migliore-
" LL YQEPVLGPVR trypsin, Samour et 
'l; 191-202 Dep I3-CN al., 1989 
'" 
: pepsin-trypsin 
1; 
, 
! ,. 
-,. 
124 
Table 5.4 (continùed) 
·'·:I",g,mz·~·· , .... "". '.' '. '.1 • '",,:.1''''' . 'd<l';"""· ,::','11&." ,.IH'1!'''·'· • 'hl' ""''"'''''' ".,m, ".' 
Peptide: : i 
MW (Da),Z , 
: , amino acid sequence 1 Bioactivity ; Origin Reference 
amino acid sequence in J>- .' 
; : eN 
.. ' 
:i 
1432.8,2 
• 
Immunomodulatory Dep p-CN Migliore-
IQAFLL YQEPVL pepsin-trypsin Samour et 
187-198 al.,1989 
..... 
"'M .. '" .. " " ,~ .. 
1 
1450.7,2 Angiotensin-l- p-CN control, Philanto-
PVVVPPFLQPEVM converting enzyme i p-CN pepsin-
, 
Leppala et 
81-93 (ACE) inhibitory ! trypsin, Dep p- al., 1998; 
, CN pep sin- 1 FitzGerald 
J trypsin 1 & Meisel, 
1 2000 
1 
, ....... 
1452.7,2 i Opio id 
1 
p-CN pepsin- 1 Chabance et 1 
LVYPFPGPIHNSL Angiotensin-l- : trypsin i al., 1998 , 
;; 58-70 converting enzyme 
i 
i: . (AgE) inhibitory 1 
.... i 
,! 1507.8,2 Angiotensin-l- 1 p-CN pepsin- Philanto-
i 
. 
PVVVPPFLQPEVMG converting enzyme i trypsin Leppala et 
81-97 (ACE) inhibitory al., 1998; 
;: ! FitzGerald 
i 
: & Meisel, 
2000 
... 
11564.7,2 Opioid Dep p-CN [ Chabance et 
VYPFPGPlliNSLPQ Angiotensin-l- pepsin-trypsin . al., 1998 
59-72 converting enzyme 
1 
, 
(ACE)if.lhi~itory , 
'.' 
....... 
1677.8,2 
: 
Opioid i p-CN pepsin- Chabance et 
LVYPFPGPIHNSLPQ Angiotensin-l- , trypsin al., 1998 
58-72 converting enzyme i 
*' ........ . ......... .... ............. ...... 
, {~Ç~2 .!.f.lh!~i!o!y ... ; 
... ......... " .... , ...... 
, 2185.1,3 ; Immunomodulatory p-CN trypsin, Migliore-
DMPIQAFLL YQEPVLGPV . i Dep p-CN Samour et 
':: R trypsin al., 1989 
::' 184-202 1 
.. , L.... , ... 
'~. ,~~"'~ .. ~.~ ... ~~--~-_.~,~~-~_ .... _~_.~_ .. ~-,-~~~.........., ~-_ .. _ .... _.~~ ........ ~ .. ,._--_ .. _-_ .. ,_ ....... _-~ .. ~ .. ~_ ........... -..... _----_ .. ~ ..... " ...... ~ 
1::. 2429.1,2 1 Opio id p-CN pepsin- Chabance et 
VYPFPGPIHNSLPQNIPPL Angiotensin-l- trypsin, Dep 13- al., 1998 
(. TQT , converting enzyme CN pepsin- , 
'" 59-79 (ACE) inhibitory trypsin , 
.... 
,... . 
12542.2,2 ~iOid p-CN pepsin- [ Chabanœet L VYPFPGPIHNSLPQNIPP Angiotensin-l- trypsin, Dep p- al., 1998 
LTQT : converting enzyme i CN pepsin-
58-79 : (ACE) inhibitory trypsin 
à .. ,1 .. , .. , • ", ... , ..... " ' ' '' ... " , 
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Table 5.4 (continued) 
....,-...---------
Peptide: 
MW (Da), Z 
•. ' amino acid sequence i 
~ amino acid sequence in J3-
eN 
2805.5,4 
SLSQSKVLPVPQKAVPYP 
QRD 
• 
Bioactivity 
Angiotensin-l-
converting enzyme 
(ACE) inhibitory 
: Origin 
, 
. 
I3-CN control, j 
i I3-CN pepsin-
; 
trypsin 
Reference 
. Murayama 
i et al., 1987; 
1 Maeno et ' 
~=====--: ~; is~:~:!:4-198 ...... -mmm;~A'::':';ng;;;';i-ot'-e:'::::'ns=in=_=I_==::;::':; P-CN c~ntrol, .al.,1996 
., SLSQSKVLPVPQKA VPYP . converting enzyme I3-CN pepsin-
ii QRD (ACE) inhibitory ; trypsin 
~ MPIQA 
; 154-199 
~ .... :~;::KF:EE~Q J_-M-.I-.~-e~-a-l-b._i-n-d-in-g-. --J ~CN ~psin 
5355.7,4 : Opioid 1 I3-CN Trypsin, 
L IHPFAQTQSLVYPFPGPIH Angiotensin-l- Dep I3-CN 
» NSL ' converting enzyme il trypsin 
~ PQNIPPL TQTPVVVPPFLQ i (ACE) inhibitory 
. PEY ' : 
,; MGVSK ' 
'l 49-97 
............................... ....... .... .. .............. i.. .... . ..•.. 
Underlined sequences reported as bioactive peptides 
Muyarama 
et al., 
1987b; 
Maeno et 
al., 1996 
Chabance et 
al., 1998 
Chabance et 
al.,1998; 
Philanto-
Leppala et 
al., 1998; 
FitzGeald & 
" Misel, 2000 
'. . .......... . 
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CHAPTER6 
EFFECTS OF DEPHOSPHORYLATION AND PROTEOLYSIS ON 
ALLERGENICITY OF CASEINS 
6.1 Justification 
Previous chapters described experiments on enzymatic dephosphorylation 
(Chapter 3), characterization ofproducts of dephosphorylation (Chapter 4) and the effects 
of dephosphorylation on proteolysis of caseins (Chapter 5). In this chapter the effects of 
dephosphorylation on case in allergenicity is described. Milk allergy is common among 
infants, young children and sorne adults and is an abnormal response of sorne individuals 
to certain proteins present in bovine milk. An important component of milk allergy 
investigation is the evaluation of the allergenic response after dephosphorylation of 
caseins, since the phosphate groups are present in the epitope regions of casein and are 
immunoreactive (Bernard et al., 2000). A significant reduction of casein allergenicity is 
highly desirable; it is worthy to investigate whether this reduction can be achieved by 
proteolytic activity and whether hydrolysis of dephosphorylated caseins can generate 
molecules not recognized by the immune system as antigens. The fourth research 
objective of this study was to investigate the effects of dephosphorylation and in vitro 
hydrolysis of caseins on allergy reduction evaluated by enzyme-linked immunosorbent 
assay (ELISA); this Chapter addresses this objective. 
127 
6.2 Material and Methods 
6.2.1 Materials 
Whole case in was obtained as described previously in Section 3.2.1. Commercial 
a-casein and p-casein standards, potato acid phosphatase (EC 3.1.3.2; activity: 1.2 
units/mg), pepsin from porcine stomach mucosa (E.C. 3.4.23.1; activity 3, 600 units/mg 
protein) and trypsin Type IX-S from porcine pancreas (E.C. 3.4.21.4; activity 16, 100 
units/mg protein) were purchased from Sigma Chemicals Co. (St. Louis, 
MO).Immunological test, ELISA, was obtained from ELISA Systems Pty Ltd. 
(Queensland, Australia). 
6.2.2 Dephosphorylation of Caseins 
Dephosphorylation of whole casein, a-casein and p-casein was conducted as 
described in Section 5.2.2. Controls were prepared under the same experimental 
conditions using the caseins without the addition of acid phosphatase. 
6.2.3 Preparation of Casein Hydrolysates 
Proteolysis of native and dephosphorylated a-casein and p-casein was performed 
according to Section 5.2.3. Controls (native whole casein, a-casein and p-casein) were 
treated similarly without the addition of proteolytic enzymes. AH hydrolyzed caseins 
were dialyzed ovemight against distilled water at 4 oC to remove salts from the buffer. 
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6.2.4 Allergenicity Evaluation 
6.2.4.1 Antigens Preparation 
Native and dephosphorylated whole, a-casein and p-casein as well as the 
products of proteolysis of native and dephosphorylated a-casein and p-casein by pepsin, 
trypsin and combined proteolysis were analyzed. 2 mg of each casein were dissolved in 
50 ml of extraction buffer, mixed and placed in a water bath (60 oC, 15 min) with shaking 
for 1 min every 5 min (ELISA Systems Pty Ltd. Protocol, 2005). The casein solutions 
were diluted to obtain a final protein concentration of 5 mg/l. 
6.2.4.2 Enzyme-Linked Immunosorbent Assay 
ELISA Systems Pt Y Ltd (Queensland, Australia) assay was used to detect casein 
residues after dephosphorylation and hydrolysis by a double antibody (sandwich) ELISA 
coated with specific anti-Bovine case in antibodies, 72 microwells were used as follows 
(ELISA Systems Pty Ltd. Protocol, 2005); 100 III casein solution was added to each well 
of the flexible round-bottom microtitre plate, followed by mixing for 10 sec and 
incubation for 15 min. A thorough washing step (x5) was used to remove excess of free 
caseins. 100 III peroxidase conjugated anti-bovine casein polyclonal antibodies was 
added to each well, mixed for 10 sec and incubated for 15 min, followed by additional 
washing (x5). 100 III stabilized tetramethylbenzidine (TMB) as substrate was added to 
each well, mixed for 10 sec and incubated for 10 min. Finally, 100 III 1 M phosphoric acid 
was added to stop the reaction. The results were read in a microplate reader (BioRad 
laboratories; Hercules, CA) set at 450 nm and 620 nm; the raw data were processed by a 
Microplate Manager V5.2 (ELISA Systems Pty Ltd. Protocol, 2005); absorbance 
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readings are obtained as the subtraction of Absorbance 450 nm - Absorbance 620 nm. A 
negative control (buffered base) and positives controls (milk powder in buffer, at 
concentrations of 1, 2.5, 5 and 10 mg/l) were included. Results were expressed as the % 
reduction of allergenicity caseins after dephosphorylation and proteolysis by using the 
following equation: 
% Redncti?~ 
AUergemcity = 100 -
6.2.5 Statistical Analysis 
Abs (Sample 4SO~20 nm) x 100 
Abs (Contro14S{}~20 nm) 
Student's t test to compare two sets of replicate measurements: i) native vs. 
dephosphorylated casein and ii) native vs. dephosphorylated casein after each different 
protease treatment, was performed using the Abs(450-620nm) data and analyzed with 
Microsoft Excel©; 95 % confidence level was used in order to establish whether casein 
modification (dephosphorylation and proteolysis) had a significant effect on reducing 
allergenicity. 
6.3 ResuUs and Discussion 
6.3.1 Effect of Dephosphorylation of Caseins on Allergenicity Reduction 
Figure 6.1 shows the antigenicity binding capacity of whole casein, a-casein and 
p-casein and dephosphorylated whole casein, a-casein and p-casein. The highest binding 
capacity (Abs450-620nm 2.72) was obtained for the a-casein fraction, followed by whole 
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Figure 6.1: Antigen-antibody binding of whole, a-casein and ~-casein (controls) 
compared to dephosphorylated whole casein, a-casein and ~-casein 
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casein (Abs450-620nm 2.32) and ~-casein (Abs450-620nm 1.37). Dephosphorylation of the 
caseins resulted in a decrease in the antigenicity binding capacity; results show Abs450-
620nm of 1.87, 1.55 and 1.04 for dephosphorylated a,-casein, whole casein and p-casein, 
respectively; these values are similar to those reported by Nentwich et al. (2004) for 
native caseins and dephosphorylated a,-casein. There was a significant difference (p < 
0.05) in the binding capacity of dephosphorylated whole case in and dephosphorylated a,-
casein when compared to the respective control caseins (non-dephosphorylated whole 
casein and a,-casein); however, no significant difference (p < 0.05) was observed between 
dephosphorylated ~-casein and ~-casein control. Table 6.1 shows the calculated reduction 
in allergenicity for each case in; removal of phosphate groups from whole casein, a,-
case in and p-caseins resulted in relatively low reduction of allergenicity of 33%, 31.2% 
and 24.4%, respectively. The lack of defined tertiary structure of caseins due to the high 
content of proline and hydrophobic amino acids (Fox & McSweeney, 1998) likely 
contributed to this relatively low reduction in allergenicity; the major epitopes containing 
the phosphate groups were probably not completely dephosphorylated. Otani et al. (1987) 
reported that modification of caseins by dephosphorylation changed their immunological 
properties; this agrees with our results which decreased IgE binding of dephosphorylated 
whole casein, a,-casein and ~-casein confirms a reduction of the antigen bonding. The 
highest binding obtained for the control a,-casein is consistent with current knowledge 
that a,-casein is the major milk allergen (Spuergin et al., 1996). Dephosphory1ation of a,-
casein is important since a,-casein plays a crucial role in allergenicity, especially as the 
phosphoseryl residues in a,s-caseins have been described as being immunoreactive and 
resistant to digestive degradation (Bernard et aL, 2000). In a review by Wal (2004), it has 
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Table 6.1: % Reduction* of allergenicity after dephosphorylation and 
dephosphorylation/proteolysis of whole casein, a-casein and ~-casein 
24.4 
61.9 
74.7 
61.9 
75.4 
* Based on average absorbance data (Abs 420-620nm) in Figures 6.1, 6.2 and 6.3 
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been suggested that there is no specific structure or function that can be associated with 
allergenicity of milk proteins due to the high variability and heterogeneity of the IgE 
response; it was stated that no single allergen or particular structure can be responsible 
for milk allergy. On the other hand, Spuergin et al. (1996) demonstrated that sera from 
allergic subjects to milk showed reactions with three regions of aSI-casein, corresponding 
to the amino acids residues 19-30, 93-98, and 141-150 which contain phosphoserine 
residues. 
6.3.2 Effect of Proteolysis and Dephosphorylation/Proteolysis on 
Allergenicity Reduction of Caseins 
Figure 6.2 shows the antigenicity binding capacity of a-casem and 
dephosphorylated a-casein obtained after peptic, tryptic and combined peptic-tryptic 
proteolysis. The highest binding capacity (Abs450-620nm 0.62) was obtained for the a-
casein peptic treatment, followed by a-casein combined proteolysis treatment (Abs450-
620nm 0.45) and a-casein tryptic treatment (Abs450-620nm 0.43). The dephosphorylated a-
casein showed a decrease in the antigenicity binding capacity after proteolysis; results 
show an Abs450-620nm 0.47, 0.41 and 0.51 for peptic, tryptic and combined proteolysis, 
respectively; there was no significant difference (p < 0.05) in allergenicity reducticll 
between the a-casein and dephosphorylated a-casein hydrolysates obtained after trypsin 
and combined pepsin-trypsin proteolysis; however, pepsin treatment showed a significant 
difference (p < 0.05) between the a-casein and dephosphorylated a-casein hydrolysates. 
Additionally, a significant difference (p < 0.05) in the reduction of allergenicity was 
noted between dephosphorylated a-casein as control (non-hydrolyzed) and the 
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proteolysis products of the same dephosphorylated a-casein obtained after the three 
proteolytic enzyme treatments. Table 6.1 shows the calculated reduction in allergenicity 
for a-casein and dephosphorylated a-casein after each proteolytic treatment; a reduction 
in allergenicity of 61.9%, 61.9% and 58.5% was obtained for the pepsin, trypsin and 
combined pepsin-trypsin proteolysis of a-casein, respectively; slightly higher 
allergenicity reduction of 74.7%, 75.5% and 71.33% was obtained for dephosphorylated 
a-casein after pep sin, trypsin and combined proteolysis, respectively. 
Figure 6.3 shows the antigenicity binding capacity of ~-casein and 
dephosphorylated ~-casein obtained after peptic, tryptic and combined peptic-tryptic 
proteolysis. The highest binding capacity (Abs450-620nm 0.60) was obtained for the ~­
casein peptic treatment, followed by ~-casein tryptic treatment (Abs450-620nm 0.44) and ~­
casem combined peptic-tryptic proteolysis treatment (Abs450-620nm 0.28). 
Dephosphorylated ~-casein showed a decrease in the antigenicity binding capacity after 
proteolysis; binding capacities were Abs450-620nm 0.48, 0.22 and 0.19 for peptic, tryptic 
and combined proteolysis, respectively; there was a significant difference (p < 0.05) in 
allergenicity reduction between ~-casein and dephosphorylated ~-casein hydrolysates 
after all proteolysis treatments; additionally, a significant difference (p < 0.05) in 
allergenicity reduction was noted between dephosphorylated ~-casein as control (non-
hydrolyzed) and dephosphorylated ~-casein after trypsin and combined pepsin-trypsin 
proteolysis. Peptic treatment for ~-casein control (non- hydrolyzed), ~-casein hydrolyzed 
and dephosphorylated showed a non significant difference (p < 0.05) in the binding 
capacity; this was also the case for ~-casein control (non-hydrolyzed) and ~-casein after 
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trypsin proteolysis. Table 6.1 shows the calculated reduction in allergenicity for ~-casein 
and dephosphorylated ~-casein after each proteolytic treatment; a reduction in 
allergenicity of 4%, 0.6% and 70.3% was obtained for the pep sin, trypsin and combined 
proteolysis of ~-casein, respectively; at this time no explanation can be given for the 
relatively low decrease in allergenicity by pepsin hydrolysis. Higher results were 
obtained for dephosphorylated p-casein 4%, 69.5% and 74.9% after pepsin, trypsin and 
combined proteolysis, respectively. 
The results demonstrated that dephosphorylation favored the proteolytic cleavage 
of regions originally containing the major phosphorylated epitopes; there is a higher 
reduction in allergenicity (more than 70%) when compared to the non-hydrolyzed native 
and dephosphorylated caseins. a-case in showed the strongest antigenic binding when 
compared to the ~-casein; an evaluation of reduction in allergenicity of a particular case in 
fraction may indicate the extent of hydrolysis necessary for efficient allergenicity 
reduction. Although, there is evidence on the reduced allergenicity of caseins hydrolyzate 
used in infant formulas (Miquel et al., 2005), the adequate degree of hydrolysis necessary 
to obtain the desired reduction in allergenicity and the particular polypeptides that are 
responsible for residual allergenicity have not been established. Commercial hydrolyzed 
formulas were evaluated for allergenic responses in children with IgE mediated bovine 
milk allergy (Caffarelli et al., 2002); it was observed that most patients tolerated 
extensively hydrolyzed casein formulas; although, highly sensitized children experienced 
immediate clinical reactions. 
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CHAPTER 7 
GENERAL CONCLUSIONS 
7.1 Conclusions 
Milk proteins are considered an active subject of research and development of 
new and improved food products and ingredients. The modern food-processing industry 
is placing more and more emphasis on the utilization of protein ingredients to provide 
specific functional properties to a wide range of formulated foods. Phosphate groups are 
responsible for many important characteristics of caseins. Modification of caseins can be 
achieved by a number of chemical and enzymatic means; this research studied the effects 
of enzymatic dephosphorylation on whole casein, a-casein and p-casein on biological 
properties of whole casein, a-casein and p-casein. 
The present work has established optimum dephosphorylation conditions for 
whole casein, a-casein and p-casein. Results demonstrated that who le case in and its 
individual a-casein and p-casein fractions showed substantial (>70%) dephosphorylation 
by an acid phosphatase. Apparent kinetic parameters Vmax (0.283 !lmol P/mg casein min) 
and Km (9.951 mg casein/l) for dephosphorylation of whole casein were obtained. 
Knowledge of these parameters is important to characterize the reaction system; the V max 
value varied with the total concentration of the phosphatase present but the Km value was 
independent of the enzyme concentration and it is considered characteristic of the 
reaction investigated. 
This work established that dephosphorylation of the whole casein did not show 
the non-specific proteolysis which was observed with a-casein and p-casein. Random 
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dephosphorylation was observed with both a-casein and ~-casein. Limited 
dephosphorylation was observed with both a-casein and p-casein in the absence of the 
phosphatase. Using ESI-MS would allow us to identify dephosphorylated species. 
Dephosphorylation of the case in fractions facilitated the proteolytic effects of 
pep sin and trypsin. The information obtained using mass spectrometry techniques about 
protein structure in conjunction with advanced bioinformatics interfaced with protein 
database search engines, resulted in the identification of peptides liberated by proteolysis 
and dephosphorylation effects on the peptides released by proteolysis. 
Evaluation of allergenicity by Enzyme-Linked Immunosorbent Assay after 
dephosphorylation of whole casein, a-casein and p-casein and proteolysis, indicated that 
there was a significant reduction of the antigen binding capacity of dephosphorylated 
casein. However, proteolysis reduced considerably more the antigen binding capacity of 
caseins compared to the entire caseins molecules. Proteolysis and dephosphorylation 
results showed a higher reduction in allergenicity (approximately 70%); especially in the 
highly allergenic a-casein after dephosphorylation and trypsin treatment. 
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APPENDIX 1 
Screen capture of portions of a typical LC-ESI-MS/MS data an~lysis search report 
of a-case in tryptic hydrolysis using ProteinLynx showing (a) list of significant hits and 
information on individually identified proteins, with the sequence of the matched peptide, 
(b) probability-based score (99.9%) illustrated by the bar chart, (c) information on 
individually identified proteins inciuding mass, charge, experimental mass and error, and 
(d) the MS/MS spectrum (ProteinLynx, Global Server 2005). 
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APPENDIX2 
Screen capture of portions of a typical LC-ESI-MSIMS data search report of (l-
casein trypsin hydrolysis using Mascot (Matrix Science, 2005), showing (a) top list of 
significant hits, (b) probability-based Mowse Score (bar chart) , (c) information on 
individually identified proteins including mass, error, and (d) sequence of matched 
peptide (Matrix Science, Mascot, 2005) 
User 
Email 
Search ti tle 
MS data file 
Database 
Timestamp 
Mascot Search Results 
aline 
aline.tezcucanoGmail.mcgill.ca 
a-casein t~sin 
E050511 lA 2.pkl 
SWissProt 47.6 (243668 sequences: 110671679 residues) 
21 Anq 2005 at 02:01:19 GMT 
Warninq Too many peptide masses in your data fUe. Mascot ha. a Umit of 1000DOO 
Siqnifloant hlts: PD2662-00-00-00 (CASl BOVIN) Splice isoform Dlsplayed: Variant Displayed 
P02663 (CAS2=BOVIN) Alpha-S2 oaseln precursor [Contains: Casooldln-lJ Alpha-S2 ~asei 
P02754-00-04-00 (LACS_BOVIN) Splioe isoform Displayed; variant variant A 
P67975 (LAC1LOVIMU) Beta-laotoqlobulin (Beta-LG) Beta-lnotoqlobulin (Beta-LG) 
P02666-00-05-00 (~B_BOVIN) Splice isoform Displayed: Variant variant B 
P0266S-00-00-00 (~KBOVIN) Splice isoform Displayed: Variant Displayed 
QSB9D5 (cATV=NPVRO) Viral cathepsin (EC 3;4.22.50) (V-oath) (Cyateine proteinase) 
Probability Based Mowse Score 
Ions score is -1 O*Log(P), where P is the probabiJity that the observed match is a random event. 
Individual ions scores> 44 indicate identity or extensive homology (p<O.05). 
Protein scores are derived from ions scores as a non-probabiJislic basis for ranking protein hits. 
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Qnery Observed Mr(expt) Mr(calc) Delta Miss Score Expeot Rank Peptide 
W 27 416.16 830.31 830.38 -0.07 0 (32) 1.8 1 K. EDVPSER. y 
R' ~ 416.17 830.33 630.38 -O.O~ 0 (31) 2.2 1 K.EDVPSER.y 
P' ~ 416.20 630.36 830.38 0.00 0 33 1.5 1 K. EDVPSER. 'l 
43 455.74 909.46 909.47 -0.01 0 (5) 4.7e+02 10 K.EGlHAQQK.E 
II 455.74 909.46 909.47 -0.01 0 9 1.ge+02 3 K.EGlHAQQK.E 
W 113 634.29 1266.57 1266.70 -0.13 0 64 0.00057 1 R. YLGYLEQLLR. L 
P' 111 634.29 1266.57 1266.70 -0.13 0 (61) 0.0014 1 R.YLGYLEQLLR.L 
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APPENDIX3 
Peptides Identified by MS from a-casein and Dephosphorylated a-casein in Section 5.3.2.1 after Enzyme Proteolysis 
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APPENDIX4 
Peptides Identified by MS from J3-casein and Dephosphorylated J3-casein in Section 5.3.2.1 after Enzyme Proteolysis 
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